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ABSTRACT
Roles of Endothelial Cell Heat Shock Protein A12B and β-glucan, a Reagent for
Trained Immunity, in the Regulation of Inflammation in Sepsis
by
Fei Tu
Sepsis is dysregulated host immune response to infection causing lifethreatening organ dysfunction. Endothelial cell dysfunction and uncontrolled
inflammatory responses are two contributors for sepsis-induced mortality. The
crosstalk between endothelial and immune cells plays a critical role in the
pathophysiology of sepsis. Therefore, understanding the mechanism of
interaction between endothelial and immune cells will provide novel information
to develop therapeutic strategies for sepsis.
Pathogen associated moleculear patterns (PAMPs) and/or damage associated
molecular patterns (DAMPs) produced during sepsis, activate endothelial cells to
increase the expression of adhesion molecules, attracting immune cell infiltration
into the tissues. Uncontrolled inflammatory responses during the early phase of
sepsis contribute to organ failure and lethality. Over 100 clinical trials, targeting
inflammatory responses in sepsis, have failed in the past three decades. Thereby,
developing novel therapeutic strategies for sepsis are urgent.
Heat shock protein A12B (HSPA12B), as one member of HSP70 family,
predominately expressed in the endothelial cells, plays important roles in many
pathophysiological processes. Currently, we observed endothelial cell specific
2

HSPA12B deficiency (HSPA12B-/-) exacerbates mortality in sepsis induced by
cecal ligation puncture (CLP). HSPA12B-/- septic mice exhibits increased
expressions of adhesion molecule and infiltrated macrophages in the
myocardium and activated macrophages in the peritoneal cavity. In vitro studies
show that HSPA12B could be secreted from endothelial cells via exosome.
HSPA12B carried by exosomes can be uptaken by macrophages to
downregulate macrophage NF-B activation and pro-inflammatory cytokine
production.
Trained immunity, induced by β-glucan, causes immune memory in innate
immune cells, with an altered response towards another challenge. We have
found that mice received β-glucan seven days before CLP sepsis exhibit
attenuated mortality with decreased pro-inflammatory responses. We found that
β-glucan significantly increased the levels of HSPA12B in endothelial cells and
endothelial exosomes. β-glucan induced endothelial exosomes markedly
suppress macrophage NF-B activation and pro-inflammatory responses.
The current data suggests that HSPA12B plays a novel role in the regulation of
immune and inflammatory responses and that HSPA12B could be an important
mediator for the crosstalk between endothelial cells and macrophages during
sepsis. β-glucan regulates endothelial cell functions and immune/inflammatory
responses, thus improving survival outcome in CLP sepsis.
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CHAPTER1. INTRODUCTION

Sepsis and Septic Cardiomyopathy
The History of Sepsis
The Previous Recognition of Sepsis. The word sepsis is originated from
“decomposition” or “decay” in the Greek, which was first recorded in Homer’s
poems dated at around 2700 years ago.1 In the following centuries, it also
appeared in the works of Hippocrates (circa 400 BC) and Galen (129–199 AD).2
In 1878, the germ theory of diseases was formally established by Pasteur, which
resulted in the recognition that sepsis is related to detrimental microorganisms.2
In 1914, a German Scientist, Hugo Schottmüller, proposed the first modern
sepsis definition, writing that sepsis is present if a focus has developed from
which pathogenic bacteria, constantly or periodically, invade the blood stream in
such a way that this causes subjective and objective symptom.3 During the
majority of the 20th century, there were still tremendous challenges in diagnosing,
treating and investigating sepsis due to no widely acceptable definition of sepsis
worldwide.4
The Modern Definition of Sepsis. In 1991, an international conference
hosted by the Society of Critical Care Medicine (SCCM) and The American
College of Chest Physicians (ACCP) developed a consensus definition of sepsis
that defined it as: systemic immune responses to infection, which was
categorized as systemic inflammatory response syndrome (SIRS), severe sepsis
and septic shock based on degree of severity.5 The definition of sepsis was
further refined to emphasis the role of organ dysfunction at the 2001 consensus
18

conference.6 With advances in diagnostic approaches and a deeper
understanding of basic science, the latest concept of sepsis was proposed by
Merinoff Symposium in 2010, whereby sepsis is defined as the life-threatening
organ dysfunction caused by host responses to infection. The new definition
mainly focused on the role of organ dysfunction in sepsis. It was widely accepted
by the Third International Consensus Conference in 2016.7
The Burden of Sepsis
Incidence of Sepsis Globally. Although the global burden of sepsis is hard
to determine due to the various circumstance in global development, data from
the World Health Organization (WHO) show that over 30 million people are
affected by sepsis annually. Data from Europe presented around 41% mortality in
septic patients. The data from a multicenter study in Australia and New Zealand
reported that the mortality rates were still close to 20%.8,9. In Spain, the
percentage of septic hospital admissions was markedly increased from 3.6% in
2000 to 5.8% in 2013. The percentage of sepsis-related deaths was significantly
increased from 18.7% in 2000 to 29% in 2013 respectively.10 A study from China
reported that the incidence rate of sepsis in major cities was increased from 0.38%
in 2003 to 0.49% in 2007 in males and from 0.40% in 2003 to 0.45% in 2007 in
females respectively.11 Thus, it is a worthy and urgent assignment for scientific
community to investigate how to effectively diagnose and cure septic patients
and substantially reduce mortality and the cost of sepsis worldwide.
The Burden of Sepsis in United States. A retrospective analysis of over
2.9 million adults admitted to US hospitals in 2014 indicated that there was no
19

significant reduction in the septic incidence and the survival outcome between
2009 and 2014.12 Moreover, the current situation of sepsis in the United States is
also a huge burden for the healthcare system. More than 1.6 million adult septic
cases occurred each year, and 258,000 septic patients died annually,
contributing to 1 out of 3 hospital deaths with more than $20 billion for the
treatment of sepsis in 2011 alone.13
Pathophysiology and Sepsis
Organ Dysfunction in Sepsis. Clinical observations indicate multiple organ
dysfunction syndrome (MODS) is more positively related with septic mortality,
where mortality could range from 11% to 54% in septic patients with MODS.14
Most recent studies have demonstrated that six major dysfunctions, including the
cardiovascular, respiratory, renal, neurological, hematological and hepatic
systems, are affected by sepsis.15–20 However, the effect of sepsis on organs is
not limited to a single organ, instead one organ dysfunction often causes another
organ failure.21 Consider the central role of the heart in the circulatory system
that is able to provide the whole body with oxygen and nutrients and remove the
metabolic waste. Cardiovascular failure caused by sepsis is capable of
exacerbating other organ dysfunctions by causing tissue hypoxia, mitochondria
dysfunction, dysregulated metabolism, and unbalanced physiological equilibrium.
Thereby, there is no doubt that cardiovascular dysfunction is an important
indicator for septic death, deserving close attention.
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Cardiomyopathy in Sepsis. Cardiomyopathy is defined as a myocardial
disorder characterized by heart muscles that are an abnormal structurally and
20

functionally. The first report about septic cardiomyopathy in a patient was
published in 1984, it has been regarded as a predictor or indicator for septic
death, which was observed in over 40% of septic patients and in nearly 70% of
septic mortality.22,23 Although there is no diagnostic criteria for septic
cardiomyopathy currently, three characteristics have been observed, increased
end-diastolic volume, decreased ejection fraction and then a returned to
normality by 7~10 days in the patients who survive.24
Mechanism of Cardiomyopathy in Sepsis
In the past, scientists have proposed two possible causes for the induction
of septic cardiomyopathy. The first explanation was a result of animal
experiments, which showed hypoxia in the myocardium caused less coronary
blood flow.25 However, Cunnion et al investigated this possibility using coronary
sinus catheterization in patients, where the coronary flow was the same or
greater than in the normal control.26 This data excludes less coronary blood flow
as the cause of septic cardiomyopathy. With a deeper understanding of septic
cardiomyopathy, many myocardial depression factors have been discovered.
Anthony et al found the depressant effects of endotoxin on the myocardium, and
observed the reduction of left ventricular function in humans with endotoxin
administration. 26,27 Following these studies, scientists have also demonstrated
cytokines, including TNF-α and IL-1β, could mimic the poor cardiac functions
caused by sepsis.28–31 Other studies unveiled other mediators for myocardium
depression in sepsis, such as energetic starvation32, damage associated
molecular patterns (DAMPs)33, cell apoptosis34, and calcium transport35.
21

DAMPs are released from host cells as danger signals that activate
immune cells, while pathogen associated molecular patterns (PAMPs) are
expressed in the pathogens but not in the host cells. Although DAMPs and
PAMPs are different, they are both recognized by shared pattern recognition
receptors (PRRs), which are proteins located on the cell membrane or cell
cytoplasm in different types of cells.36 Although researchers have already
realized that DAMPs/PAMPs could be the triggers for activation of innate immune
and inflammatory responses, resulting in septic cardiomyopathy, the discovery of
Toll-like receptors (TLRs) that could recognize DAMPs/PAMPs enabled scientists
to understand those processes in sepsis.37 Now, at least 10/11 different TLRs
have been identified in the human and mouse.38 TLR1, TLR2, TLR4, TLR5 and
TLR6 are located on the cell surface, recognizing and binding various
components of cell walls or membranes of pathogens, whereas TLR3, TLR7,
TLR8, TLR9 and TLR13 are on the endosomes of cells and target self or no-self
nucleic acid.37 TLR4 is the receptor of endotoxin/LPS, which not only is
expressed on immune cells, including macrophages39, dendritic cells40, and
neutrophils41, but is also identified on non-immune cells, such as endothelial
cells42, adipocytes43 and myocytes44. It is widely accepted that infiltration of
immune cells, such as the macrophage and the neutrophil, into the myocardium,
resulted in cardiac dysfunction during sepsis.45,46 The previous studies by our lab
demonstrated that TLR3 exerts a deleterious role in sepsis-induced cardiac
dysfunction, which was associated with activation of TLR4-medicated NF-B and
TRIF-dependent IFN signaling pathways as well as the upregulation of adhesion
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molecules, such as VCAM1 and ICAM1, in the myocardium.47 However, TLR9
activated by CpG-ODN attenuated cardiac dysfunction by activation of both
PI3K/Akt and ERK signaling.47 Besides other members of the TLR family, TLR3
and TLR4 areexpressed at a high level in the human umbilical vascular
endothelial cells (HUVECs) and human microvascular endothelial cells
(HMVECs).48 LPS/endotoxin can also activate TLR4 on the endothelial cells to
induce endothelial permeability, promoting the progression to cardiac
dysfunction/failure.49 Moreover, endothelial activation by TLR ligands leads to the
upregulation of ICAM1 and VCAM1 expressions, which contributes to monocyte
and neutrophil infiltration into the myocardium during sepsis.50 Thus, it is
necessary to understand well the roles of TLRs, immune cells, and endothelial
cells in the cardiomyopathy caused by sepsis.
Role of Endothelial Cells in Sepsis
Functions of Endothelium
Endothelium composed of endothelial cells forms barriers by cell-cell
junctions, such as adhesion junctions (AJ), gap junction (GJ) and tight junctions
(TJ), between the circulation system and other tissues.51 The endothelium also
senses hemodynamic forces, regulate coagulation and hemostasis, and
modulate immune cell patrolling on the surface of endothelium or infiltration
through endothelium.51 Endothelial cells widely distribute among organs.
Therefore, the homeostasis of endothelium is crucial to maintain organ
physiological function. As a first line of defense against internal and external
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stimulators, including cytokines, chemokines, DAMPs/PAMPs, growth factor and
others, the responses of endothelial cells are critical to the following responses.
Dysregulated Endothelial Cell Function during Sepsis
Glycocalyx shedding in sepsis. Since the latest definition of sepsis
released in 2016, the contributions of endothelial dysfunction to multiple organ
dysfunctions in sepsis have received more and more attention. The integrity of
the endothelial cell lining is tightly regulated by the glycocalyx and the endothelial
cytoskeleton, both of which can be disrupted during sepsis.49 The glycocalyx
consists of proteoglycans and glycoproteins, lining the luminal side of
endothelium as a thick gel-like layer.52 Glycocalyx has been shown to be shed
from endothelium in the presence of oxidants, cytokines, and endotoxin in the
circulation.49 This shedding is highly related to the occurrence of many diseases,
including sepsis. Glycocalyx has been found to modulate a variety of processes
during sepsis, such as endothelial barrier function, immune cell adhesion, and
inflammatory responses.49 Eric et al found that glycocalyx shedding was caused
by TNF-α in sepsis-induced acute lung injury, which was accompanied by
neutrophil adhesion and inflammation.53 With glycocalyx shedding, the
endothelium is exposed to the circulating leukocytes and leukocyte released
cytokines, which activate endothelial cells to express adhesion molecules, such
as VCAM1, ICAM1 and selectins, to assist immune cell adhesion following
transendothelial migration into the tissues.49,54 In addition, shedding of glycocalyx
also resulted in edema formation, which is a serious result of the loss of the
barriers of endothelium and a predictor for organ failure in sepsis.55
24

Hemostasis and Endothelium in Sepsis. The initiation of sepsis not only
induces dysregulated immune responses, but also uncontrolled hemostasis at
different stages of sepsis.56 The complicated hemostatic system is made of the
endothelium, platelets, coagulation factors and leukocytes.49 Tissue factor (TF) is
a procoagulant transmembrane glycoprotein produced by endothelial cells under
normal conditions.49 It is induced by endotoxins, and cytokines, which form a
complex with factor VIIa and ultimately promote final fibrin clot formation. 57–59
Moreover, endothelium regulates anticoagulation by the endothelial protein C
receptor, by activating protein C to reduce factor V, factor VIII and PAI-1, which
involves the regulation of fibrinolysis in the normal situation, and could be
activated by inflammation. In the early stages of sepsis, pro-inflammatory
responses induce hypocoagulation, resulting in vascular occlusion, which is a
key inducer for organ failure.60However, with the development of sepsis, the
situation of hypo-coagulation accompanies the consumption of platelets and
coagulation factors in the later phase of sepsis.61,62
Inflamed Endothelium in Sepsis. Although endothelial cells are not
considered as subsets of immune cells, PRRs have been observed to express on
the endothelial cells, including TLRs, NOD-like receptors (NLRs) and RIG-I-like
receptors (RLRs). These PRRS recognize PAMPs/DAMPs from different
sources.63,64 This information explains why endothelial cells could secret proinflammatory cytokines, such as TNF-, IL-6 and IL-8, in the presence of
microbial components.65,66 Moreover, endothelial cells have also expressed MHC
class I and class II.67 Only antigen presenting cells (APCs) present MHC II
25

expression, indicating the capability of endothelial cells to initiate adaptive
immune responses.68 Due to all of this, endothelial cells have been regarded as
conditional innate immune cells. PAMPs/DAMPs, during sterile or microbial
sepsis, are capable of activating endothelial cells to express adhesion molecules,
such as ICAM1, VCAM1 and E-selectin, and chemokines on the luminal side to
assist leukocyte migration into the tissues. The cytokines released from
endothelial cells not only recruit more monocytes and neutrophil infiltration to
destroy invading microbes, but also induce ROS production by activating NADPH
oxidases to modulate immune cell activation and kill pathogens.69 If not quickly
and effectively resolved, excess inflammation induced by endothelial cells can
result in irreversible organ damage by loss of endothelial barrier function,
increased ROS production and severe hypercoagulation.69 The NF-B signaling
cascade in endothelial cells plays a critical role in the regulation of adhesion
molecule expression, inflammatory responses, coagulation processes and
endothelial barrier function.70
Role of Endothelial Cells in Cardiac Function. The heart is a complex
organ consisting of several cell types, including cardiomyocytes, endothelial cells,
fibroblasts, and diverse immune cells.71 Among them, endothelial cells and
cardiomyocytes represent the majority of cardiac cell types.72 Considering the
limited proliferation of cardiomyocytes, recent evidence highlights the key role of
endothelial cells in cardiac repair/cardiac regeneration.73 Endothelial related
inflammation, coagulation and barrier function are critical to normal cardiac
function.33 The contribution of endothelial cells in neutrophil/monocyte infiltration
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into the myocardium during sepsis is via the production of pro-inflammatory
cytokines, such as TNF-α and IL-1β, to attract neutrophils/monocytes, as well as
the increase of the expression of adhesion molecules, such as ICAM1 and
VCAM1, to assist neutrophil/monocyte migration.74,46 Our lab’s previous studies
have demonstrated that accumulated neutrophil/monocyte infiltration in the
myocardium plays an important role in sepsis-induced cardiac dysfunction.75 In
addition, increased ROS from endothelium has been found to induce cardiac
dysfunction through dysfunctional isometric contractions of cardiac trabeculae in
sepsis.76 Due to the significant role of endothelial activation during sepsis, multicenter validation studies have demonstrated the positive associations between
biomarkers of endothelial cell activation and sepsis severity, organ dysfunction
and septic mortality.77,78
Heat Shock Proteins
Heat Shock proteins (HSPs) were evolutionarily conservative proteins in
both prokaryotes and eukaryotes, whose induced expression were found in
temperature-shocked Drosophila in 1964.79,80 HSPs are a large group of proteins,
consisting of several subfamilies, which are classified by their molecule weight.
They are small HSPs (≤ 34KDa), HSP40 (35~ 45KDa), HSP70 (65~80KDa),
HSP90 (81~99KDa) and HSP110 (≥ 100KDa).81 The basic contribution of HSPs,
in stressed and unstressed conditions, is based on their chaperone function,
which maintains native protein structure, facilitates deformed protein refolding,
and aids in protein translocation.82 Apart from their responses to heat shock,
HSPs can be induced by various stimulations, such as starvation 83, hypoxia84,
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infection85, and inflammation86. Due to their widespread distribution in the body,
they have been found to play significant roles in many physiological pathological
processes, such as neurodevelopment87, cell proliferation88, metabolism89,
tumorigenesis90, cardiovascular diseases91, and sepsis92.
Roles of HSPs in Inflammation and Sepsis
HSPs play protective roles within the intracellular environment, but present
as immunomodulators in extracellular settings.93 Intracellular HSP7294, HSP7095
and HSP9036 are able to protect cells from stress-induced apoptosis by blocking
caspase activation, and activating PI3K/Akt signal pathways. Among the HSP
family, HSP70 and HSP90, as both intracellular and extracellular HSPs,
modulate immune responses in immune cells with or without stimulations. 96–98
Increasing evidence indicates both the anti-inflammatory role of intracellular
HSP7099,100 and HSP90101,102 by inhibiting NF-B signal pathways, and the proinflammatory function of extracellular HSP70103,104 and HSP90101,105. Schroeder
et al discovered that endotoxin reduced HSP70 expression in peripheral blood
mononuclear cells from severe septic patients with increased IL-6 expression,
indicating the protective role of HSP70 in sepsis.106 In addition, HSP70 has also
been reported to ameliorate ROS, inflammatory responses in myeloid cells after
lipoteichoic acid stimulation.107 However, Silva’s study found that reduced serum
HSP70 levels are positively related with improved survival outcome in septic
animals.108 This clinical observation showed significantly increased serum
HSP70 in non-survival septic patients compared with control and septic survival
patients.109 This conflicted function of HSP70 in sepsis indicates the complexity
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of septic occurrence, such as the distinct responses in animals and humans
under sepsis, different pathophysiological conditions among septic patients, and
the diverse approaches for the treatments of sepsis.
Discovery of HSPA12B
In a study of the development of atherosclerotic lesions, Han et al
discovered, for the first time, two new HSP70 family members by gene
expression profiling, named HSPA12A and HSPA12B, which have an atypical
HSP70 ATPase domain separated by spacer amino acids.110 Both proteins are
highly conserved in between human and mice with distinct tissue-specific
expression patterns. In the following study, Han and his colleagues have
demonstrated HSPA12B is predominantly expressed in the endothelial cells in
vivo and in vitro, which is necessary for angiogenesis and endothelial cell
migration.111 Meanwhile, another group identified the HSPA12B orthologue in
zebrafish also highly expresses in vasculature and in vitro endothelial cells,
which contributes to zebrafish vascular development and endothelial cell
migration required Akt phosphorylation.112
The Contributions of HSPA12B in Pathophysiology
Zhu et al113, discovered, for the first time, HSPA12B plays a protective role
in endotoxin-induced cardiac dysfunction. The mechanisms by which HSPA12B
protected the myocardium from endotoxemia involve decreased the expression
of adhesion molecules, such as ICAM1 and VCAM1, resulting in reducing
leucocyte infiltration into the myocardium during endotoxemia. Moreover,
HSPA12B attenuated endotoxin-induced vascular inflammation, by attenuating
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increased iNOS and decreased eNOS expression, and NF-B signaling in the
myocardium. The activation of the PI3K/Akt signaling pathway is necessary for
the protective role of HSPA12B in endotoxin-induced cardiac dysfunction. Ma et
al114 reported the protective role of HSPA12B in cerebral ischemia/reperfusion
(I/R) injury, which is through preventing I/R-induced blood–brain-barrier (BBB)
permeability and attenuating I/R-induced apoptosis. Other studies have also
demonstrated the protective roles of HSPA12B in myocardium infarction by
alleviating cardiac dysfunction and remodeling115, in sepsis-induced lung injury
by reducing neutrophil infiltration and apoptosis116 and in recovery after ischemic
stroke through an eNOS-dependent mechanism117. Wu et al118 found HSPA12B
in endothelial cells is able to prevent LPS-induced increase in pro-inflammatory
cytokine production, such as TNF-α and IL-6, which accompany by reduction of
adhesion molecules, such as ICAM1, VCAM1 and E-selectin. HSPA12B was
surprisingly observed in the plasma of septic mice and septic patients. The level
of HSPA12B in the plasma of septic patients is positively correlated with the
outcome of severe septic patients, which indicates the potential biomarker of
HSPA12B to predict the poor outcome of patients with severe sepsis.
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In our

current study, we investigated the mechanisms by which HSPA12B protect
against sepsis induced endothelial dysfunction, which is a major cause of organ
dysfunction during sepsis.
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Immune Response/Inflammation in Sepsis
Immune Responses in Sepsis
In the last three decades, there have seen huge advances in the
understanding of sepsis and in sepsis management clinically. However, the
mortality induced by sepsis is still around 30% in the ICUs.120,121 This is due to no
FDA-approved drug for treatment of sepsis at the present. Although initially
cytokine storm was thought to be responsible for sepsis induced mortality, this
has now been disproven and it is not a viable therapeutic approach122. In
addition, surviving patients over the initial pro-inflammatory stage develop a
prolonged immunosuppressive stage, which causes poor responses to
secondary challenges.123,124 This biphasic effect provides a novel perspective on
how the immune system responds during sepsis.
Hyperinflammation in Sepsis. Once sepsis occurs, the stimulators from
pathogens, such as bacteria, fungi and virus, are recognized by PPRs on the
innate immune cells and initiate immune responses. If there is no effective
immune resolution in the first three days, hyperinflammation causes more than
70% of septic deaths.123 In this hyperinflammatory phase, several intracellular
signaling that regulates pro-inflammatory cytokine and chemokine productions in
innate immune cells include mitogen activated protein kinases (MAPKs); signal
transducers and activators of transcription (STAT); Janus Kinases (JAK) and
nuclear factor κ-light-chain-enhancer of activated B cells (NF-B).125 Such
extensive and sustaining inflammatory cytokine productions result in tissue
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damage, cellular compromise, and molecular dysregulation, which induce
multiple organ failure and its associated subsequent mortality.3
Immunosuppression in Sepsis. While hyperinflammation contributes to
septic mortality, a host of recent scientific evidence and clinical observations
indicate that immunosuppression plays a key role in sepsis mortality.126–129
Moreover, epidemiological surveys display the highest morbidity of sepsis in
older patients, who do not respond to immune challenges as strongly as the
young.130,131 Increased age in patients is also associated with raised septic
mortality, which makes up the highest mortality in patients over 85 years old.132–
135

Previous studies have shown that resolution of the hyperinflammatory phase

starts several days after the initial cytokine storm. However, recent evidence
unveils the co-existence of anti-inflammatory responses and pro-inflammatory
responses after sepsis initiation.136 Clinical observation has discovered that there
is a substantial loss of cells, including innate immune cells and adaptive cells,
induced by apoptosis.127,128 Also, research in pediatric patients dying of sepsis
indicates apoptosis-induced loss of immune cells.137,138 However, regulatory
immune cells, such as T regulatory cells (Tregs)139–141, and myeloid derived
suppressor cells (MDSCs)142, increase their populations during sepsis. Thus, the
combination of decreased immune effort cells and increased regulatory immune
cells results in the immunosuppressive situation in sepsis. The anti-apoptotic
approach to halt the death of immune effector cells has been reported to result in
increased survival outcome in the septic animal models.143–145
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Cellular Defects in Sepsis
Neutrophils. are the primary innate immune cells in the first-time response
to infection146. Neutrophils are rapidly activated and possess the ability to
eradicate invading pathogens by phagocytosis147. In addition, ROS released from
neutrophils boosts microorganism eradication upon reaching the infected
areas.148 It is evident that neutrophil extracellular traps (NETs)149 released from
neutrophils could eliminate a wide range of pathogens, which consist of DNA,
cytoplasmic proteins and histones150. During sepsis, the short half-life of
neutrophils is expanded with neutrophil dysfunction, which results from increased
anti-apoptotic protein expression.151 Several signal pathways have been reported
to be involved in the resistance of apoptosis by increasing anti-apoptotic protein
expression, such as MAPK pathways, and decreasing pro-apoptotic proteins in
neutrophils, such as ERK pathways and PI3K pathways, which provide survival
signaling in neutrophils with persistent inflammation.152,153
From clinical research, scientists discovered an increased percent of
immature band-like neutrophils from bone marrow in the circulation of septic
patients.154 Further studies have demonstrated the deficits of immature band-like
neutrophils in ROS production155, cell migration156,157, and bacterial clearance158.
These observations of deficits in TLR2 signaling pathway159, chemotaxis
reduction160 and immune senescence161 contribute to neutrophil dysfunctions
during sepsis. Multiple studies have indicated that combined use of immature
neutrophil count with other biomarkers could be useful approach to diagnose the
occurrence of sepsis.162,163
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Monocyte/Macrophages. The diversity of macrophages in the tissues
display a vital role in physiologic homeostasis throughout life.164 Macrophages in
the tissues were recognized predominately from monocytes that move into the
tissues and then differentiated into macrophages, which have various names,
such as kupffer cells in the liver, intestinal macrophages in the gut, osteoclasts in
the bone, and Langerhans cells in the skin.165 This concept of monocytes as
precursors of macrophages in various tissues has been challenged by the recent
discovery that tissue macrophages originate from precursors during early
embryogenesis and have an ability to self-renew to maintain cell population.166,167
This novel concept explains rather well how microglia cells in the brain originate
from yolk sac precursors, but not from bone marrow derived monocytes. The
reason why macrophages are important to sustain normal physiology is their
contributions in the phagocytic activity of removing dead cells, as a major role of
innate immunity, and in antigen-presentation in adaptive immunity. In addition,
macrophages in different tissues are involved in distinct physiological processes,
such as promoting bone generation by osteoblasts168; modulating synaptic
maturation by microglia cells169; maintaining lung homeostasis by alveolar
macrophages170; and orchestrating cardiac repair by cardiac macrophages171.
The functions of macrophages in different tissues result from their
plasticity during physiological or pathological progresses. Macrophages have
been classified into classically activated or M1 macrophages and alternatively
activated or M2 macrophages.172 M1 macrophages preferentially express iNOS
in the presence of either IFN-γ or IFN-γ associated with LPS and produce pro34

inflammatory cytokines, such as IL-1β, TNF-α, IL-6 and IL-23; while M2
macrophages markedly present arginase in the present of IL-4 and produce antiinflammatory cytokines and growth factors, such as IL-10 and TGF-β.173 Multiple
transcription factors regulate M1/M2 polarization, such as interferon regulator
factor (IRF), STATs, and suppressor of cytokine signaling (SOCS) proteins.174
Macrophages are capable of switching towards M1 states via activation of the
IRF/STAT1 pathway with the presence of IFNs and TLR agonists, or by skewing
towards M2 states via activation of the IRF/STAT6 pathway with the presence of
IL-4 and IL-13.175 Macrophage polarization could also be induced by low levels of
oxygen (hypoxia).176 Hypoxia is involved in the regulation of macrophage
polarization by two subsets of hypoxia-induced factor (HIF), HIF-1α and HIF-2α,
whereby HIF-1α promotes M1 macrophage polarization and HIF-2α enhances
M2 macrophage polarization.177,178
In the early stage of sepsis, macrophages, which are a major source of
cytokines, are activated by PAMPs from invading pathogens, and differentiated
into M1 macrophages to assist bacterial eradication or damaged tissue clearance
and produce a mass of pro-inflammatory cytokines, such as IL-1β, TNF-α, IL-6
and IL-8.179 Massive amounts of apoptosis factors produced by overactivation of
macrophages in the early phase of sepsis, inversely promote macrophage
apoptosis, which has been observed in human autopsies and animal septic
models.180,181 Survivors of the early phase of sepsis display an
immunosuppressive phenotype with characteristics of M2 macrophages by
simultaneously displaying both downregulated pro-inflammatory cytokine
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productions, and upregulated anti-inflammatory cytokine productions.182 Clinical
observation found a deficit in producing proinflammatory cytokines in LPSstimulated septic monocytes, described as “endotoxin tolerance”.183 Chiara et al
has shown that monocytes during endotoxin tolerance display an M2 skewed
inflammation via inhibiting the NF-κB signal pathway by p50.184 The
immunosuppression of monocytes is associated with decreased HLA-DR
expression on the monocytes, which correlates with septic mortality in
patients.185,186 Until now, no clear explanation of monocyte-associated endotoxin
tolerance or immunosuppression in sepsis existed. However, current research in
epigenetics highlight sepsis induced epigenetic modification in immune cells,
which may provide potential targets to predict or diagnose the occurrence of
sepsis.187
MDSCs. Myeloid-derived-suppressor cells (MDSCs) are immature myeloid
cells that regulate the immune responses in many pathological processes, such
as cancers188,189, autoimmunity190, and infectious diseases191. The major
characteristic of MDSCs is derived from their immunosuppressive functions
whereby they suppress the production of L-arginine, promote the secretion of
anti-inflammatory mediators (IL-10, and TGF-β) and induce Tregs activation.192
L-arginine, as the product of ROS and RNS, is a semi-essential amino acid to
maintain the function of T cells193 and natural killer (NK) cells194. IL-10 and TGFβ from MDSCs could polarize monocytes/macrophages and T cells into an M2
state and a Th2 state with immunosuppressive situations.142,195 Myeloid
differentiation primary response 88 (MyD88), nuclear factor I A (NFIA) and
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glycoprotein 130 (GP130) have all been reported to modulate
immunosuppressive functions of MDSCs by promoting MDSCs expansion during
pathological conditions.142,196,197
Due to the immunosuppressive role of MDSCs, they are regarded to have
dual roles in the different stage of sepsis. The protective role of MDSCs might be
involved on the early stage of sepsis to dampen cytokine storm-induced mortality,
but MDSCs operate negatively to sustain or prolong the immunosuppressive
situation, then cause sequential persistent inflammation-immunosuppression and
catabolism syndrome (PICS). Animal experiments exhibit different functions of
MDSCs between early phase (3~5 days) and late phase (10 days) of the spleen
of septic mice.198 Early MDSCs stimulated with GM-CSF produce more
inflammatory cytokines, while late MDSCs express more anti-inflammatory
cytokines.199 However, clinical studies highlight the deadly effects of MDSCs.192
Clinical observations reveal that the level of MDSCs in the blood is positively
related with nosocomial infections and mortality of septic patients.200,201 Due to
undetectable levels of MDSCs in healthy blood, MDSCs have been regarded as
a promising biomarker to predict the outcome of septic patients. Inhibiting MDSCrelated immunosuppression is an attractive approach for the treatment of sepsis.
Gamma delta T cells (γδ T cells). Based on the subsets of antigen
receptor expression in the lymphocyte membrane, there are two types of T cells,
αβ T cells and γδ T cells. Although γδ T cells are make up only a tenth of the
total T cells in circulation, the majority of them locate in the mucosa to play a role
in the first line of defense.202,203 Different from αβ T cells, the antigen recognition
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of γδ T cells does not depend on interaction between receptors and the major
histocompatibility complex (MHC).204 Additionally, γδ T cells were first obseved to
recognize phosphorylated microbial metabolites and lipid-peptides.205,206
Activated γδ T cells produce pro-inflammatory cytokines and chemokines, such
as IFN-γ, IL-17, TNF-α, CCL3, and CCL-5.207
In animal models of sepsis, deficiency of γδ T cells correlates with
increased mortality, which results from poor bacteria clearance, and increased
proinflammatory cytokine production.208,209 Clinical studies have also
demonstrated the positive relationship between septic mortality and a diminished
population of circulating γδ T cells.210,211 The reduction of γδ T cells during sepsis
is probably caused by apoptosis-induced cell death in the intestinal mucosa with
a subsequent higher risk to secondary infections.212
Tregs. Regular T cells (Tregs) are a distinctive subset of helper T cells,
which are involved in the suppression of immune responses to sustain
homeostasis. Markers used to recognize Tregs are combinations of CD4, CD25,
and FOXP3 in mice, though this same combination is hard to characterize Tregs
in humans. However, the discovery of the methylation status of the Treg-specific
demethylated region (TSDR) assists the identification of the “real” Tregs in
humans213, which is not an ideal tool to isolate Tregs. In the clinical study, the
combination of CD4+CD25+CD127- is used to purify Tregs in humans.214
Adoptive transfer of ex vivo CD4+CD25+CD127- Tregs in humans display
protective roles in chronic graft versus host disease (GvHD) with their
immunosuppressive functions.215 There are two types of Tregs, natural Tregs
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(CD4+CD25+) and adaptive Tregs (CD4+D25-), natural Tregs being derived from
thymus and adaptive Tregs being induced from antigen in the periphery. 216
The suppressive function of Tregs is through a direct or an indirect way to
regulate various immune cell subsets. Tregs have been found to suppress
adaptive cell immunity by inhibiting T cell activation by cell interaction217 and by
dampening B cells, functioning as APC218. In addition, Tregs are able to polarize
monocyte into M2 states, inhibit functions of dendritic cells by CTLA-4 and LAG-3
and suppress neutrophil inflammatory responses.218 In a septic patient study, a
mounting percentage of CD4+CD25+CD127- Tregs present at the early time of
sepsis with decreased proliferative responses of blood mononuclear cells after
stimulation.140 Moreover, increased levels of Treg cells are also observed in
septic animal experiments. Increased levels of biomarkers in Tregs from septic
patients, such as FOXP3 and CTLA-4, indicate a higher possibility of death by a
prolonged immunoparalysis.219 An animal experiment to block Tregs with
antibodies against CD4 and CD25 do not change mortality in the septic mice 220,
and a similar result is also observed in another group by depleting CD25+ cells
before CLP221. However, Heuer et al discovered the adaptive transfer of
CD4+CD25+ cells in septic mice significantly improves survival.222 This
controversial result indicates the difficulty of consistent identification of Tregs,
which would aid our understanding of the characteristics of Tregs during sepsis.
B cells. B cells are traditionally recognized by their ability to produce
antibodies.223 Current research has revealed the diverse functions of B cells,
such as antigen presentation224, and cytokine production225. It is evident that B
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cells contribute to both innate and adaptive immunities.

226

Murine B cells have

been observed to express all TLRs (TLR1-9), and TLR agonists could activate B
cells to produce cytokines, including IL-6, IL-10, IL-12 and IFN-γ.227 B1 cells, as a
specific subset of B cells, is one of the major sources of IL-10, which could inhibit
the phagocytic function of macrophages in vitro.228
From clinical observation, we see distinct patterns shown in the circulating
B cells between septic survival and septic death, wherein a high percentage of
CD80+ and CD95+ and a low percentage of CD23+ on B cells are effective
indicators for mortality in septic patients.229 Additionally, innate response
activator (IRA) B cells, derived from B1a cells, are surprisingly observed to
produce GM-CSF, which is thought to be produced in vivo by macrophages and
T cells in some cases.230 In mice, a deficiency of IRA B cells dampens bacterial
eradication, elicits a cytokine storm, and causes septic shock.230 In the following
study, IRA B cells are reported to produce IL-3, promoting the production of
monocytes and neutrophils for cytokine storms during sepsis. Moreover, the
levels of IL-3 are positively related to mortality in the septic patients.231
Considering both the higher morbidity of sepsis and reduction of IgM production
in the elderly, it is necessary to better understand the role of B cells during sepsis.
Exosomes
Cell communication among cells in multi-cellular organisms depends on
junctions connecting neighboring cells, or is performed through paracrine
signaling which releases messenger molecules to affect neighboring cells in the
short distance, while hormones are the main regulators to modulate the functions
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of targeting cells in the long distance in both plants and animals. Extracellular
vesicles (EVs) that are secreted from all cells are involved in cell communication,
which are evolutionally conserved from bacteria and to human.

232–234

Based on

the vesicle size, EVs have been classified as exosomes (50-150nm in diameter)
and macrovesicles (50-1000nm, up to 10μm in some situations in diameter).
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The Discovery of Exosomes
In 1987, Johnstone et al discovered that exosomes, sized at ~50nm, could
be harvested from reticulocytes with centrifugation at 100, 000x g for 90min.
Exosomes were first thought to carry cellular waste during the maturation of
reticulocytes to erythrocytes.236 In 1996, Raposo et al discovered exosomes
secreted from B lymphocytes contain MIIC (major histocompatibility complex
[MHC] class II-enriched compartment) and could stimulate T cell responses.237
This result indicates the biological function of exosomes among cell
communications. In the following study, exosomes are observed to be secreted
from dendritic cells that induce anti-tumour immune responses238. To date,
exosome secretions have been found in most cell types, such as tumor cells239,
immune cells240, stem cells241, endothelial cells242, epithelial cells243 and
neurons244. It is evident that the components of exosomes are various, including
4400 proteins245, 194 lipids246, 1639 mRNAs, and 764 miRNAs247,248. Considering
the complex cargos and communicative roles of exosomes, research on
exosomes provides valuable insights and therapeutic approaches for a variety of
diseases.
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Methods to Extract and Identify Exosomes
Due to our current knowledge of exosomes, they are identified based on
size, morphology, flotation density and protein markers. Thus, approaches to
extract and identify exosomes are derived from those mentioned characteristics.
Extractions of Exosomes
Ultracentrifugation. Ultracentrifugation is a conventional method to harvest
exosomes, which are hard to acquire in a pure state due to the existence of
macrovesicles, apoptotic vesicles and others.249–251 Thus, density gradient
ultracentrifugation is introduced to overcome partially the disadvantages of
ultracentrifugation. The centrifugation begins at 230x g to remove cellular debris,
then process to remove macrovesicles at 10,000x g, and finally end at 100,000x
g to pellet exosomes.252,253 Although the purest exosomes are harvested from
density gradient ultracentrifugation, it is both time-consuming and labor-intensive
as well as requiring expensive equipment.254 Thereby, this method is not suitable
for clinical samples.
Size-Based Filtration and Polymer Precipitation. Ultrafiltration is a sized
based method to isolate exosomes, which does not need special equipment and
is faster than ultracentrifugation. A large volume of cell medium is concentrated
into a low volume of medium with the Centricon Plus-70 Centriifugal Filter device
centrifuging at 3500x g at 4°C.255 However, the limit of ultrafiltration is to separate
contaminating proteins from exosomes.
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Polymer precipitation is a simple, and rapid way to precipitate exosomes
in the “polymer nets” by low-speed centrifugation. The polyethylene glycol (PEG)
based method inherits the same mechanism to harvest exosomes. 256 Cell
medium or biological fluid is centrifuged at 2000x g for 30min to remove cellular
debris, followed by the medium supernatant mixed with PEG reagent overnight
prior to being centrifuged 3000x g for 30min. Finally, pellets are suspended with
PBS. The limit of the PEG-based method is co-precipitation of non-vesicular
contaminants, such as lipoproteins and PEG.
Immune-Affinity Purification. This method is based on the protein-protein
interaction that a large quantities of proteins expressed on the exosome
membrane, as antigens, bind with specific antibodies.257 Immuno-affinity based
techniques take advantage of membrane-bound biomarkers, not mixed with
soluble counterparts, to purify exosomes from a complex source.258 Since there
are different levels of various markers on the exosomes, individual antibody is
used to isolate exosomes from a specific cell type.259 Chang et al developed
CD34+-coating magnetic microbeads to isolate only CD34+ exosomes from acute
myeloid leukemia, which contains unique marker, CD34.260 The ELISA-based
method is another useful approach to harvest exosomes by different antibodies.
The quality and quantity of exosomes captured by the ELISA-based method are
comparable to the production of the ultracentrifugation. To enhance the yields of
exosomes, submicron-sized magnetic particles are created to produce 10 to 15
times higher levels of exosomes than ultracentrifugation.261 The advantage of the
immune-affinity approach that it is without volume limitations. However,
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properties of exosomes are not consistent for the different markers used in the
exosome isolation.
Microfluidics-Based Isolation. To overcome the current challenge of
isolating exosomes in the clinical practice, microfluidics-based technologies have
been developed to isolate, detect and analyze exosomes, based on both physical
and biochemical characteristics. This method not only takes advantage of the
size, density and immunoaffinity of exosomes, but also incorporates other novel
sorting mechanisms, such as acoustic, electrophoretic and electromagnetic
settings; nano-based traps; and viscoelastic flow.262–264 Wang et al developed a
microfluidic structure to separate exosomes from proteins, other extracellular
vesicles and cellular debris, using ciliated nanowires to trap exosomes with
40~100nm diameters.265 Kanwar et al created a simple and low-cost platform,
called “Exochip”, to capture specific exosomes in the circulation, which could be
regarded as biomarkers to diagnose the occurrence of cancers.266 These cuttingedge techniques provide promising approaches to exosome isolation for point-ofcare and clinical applications.
Characterizations of Exosomes
Transmission Electron Microscopy. As the gold standard to measure
exosomes, transmission electron microscopy (TEM) is used to qualify and count
exosomes. There are still several deficits in counting exosomes by TEM, which is
time-consuming, labor-intensive, and low-yield.267 For the complex processes of
sample preparation, the electron beam could damage the exosome biological
features and cause damage in shape.268 Modifications on standard TEM, cyro44

EM has been developed to the damage during the sample preparation without
influencing dehydration and fixation for TEM.269,270
Nanoparticle Tracking Analysis. Based on examining the size of
exosomes, nanoparticle tracking analysis (NTA) was created to scale the
concentration and size distribution of EVs ranging from 10nm to 2000nm in
diameter.271 NTA utilizes Brownian motion of nanoparticles in a fluid to track the
movement of exosomes. The outcomes of NTA are the size, size distribution,
concentration, and phenotype of EVs. In addition, NTA combing with
fluorescence could be used to analyze conjugated quantum dots. The advantage
of utilizing NTA is timesaving within minutes and to maintain the native situation
of EVs.
Dynamic Light Scattering. Dynamic light scattering (DLS) is a technique
to measure the size of exosomes based on the scattering of a laser beam. 272
DLS is able to record the intensity of the scattered light as a function of time by
observing the movement of particles in a liquid suspension. The advantage of
DLS is that it is capable of measuring EVs sized from 1nm to 6000nm. However,
there are some shortcomings by DLS as well.272 First, DLS could not provide
visualized results of exosomes. Second, due to the characteristics of scattering
light, even a small amount of large particles could influence the accuracy of
detection.273,274 Third, DLS is not able to display any biochemical information of
EVs. The application of DLS has been used to access EVs from red cells and
cancer cells.275,276
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Flow Cytometry. The basic mechanism of conventional flow cytometry is
to measure particles over 300nm in diameter, and is without the ability to detect
exosomes due to the size limitation.277 However, a modified flow cytometer with
higher-sensitivity forward scatter detection could detect exosomes labelled with
fluorescent dyes from background signalings.278,279 The new generation of flow
cytometers is able to detect exosomes with a higher EV resolution by multiple
angles by forward scatter light detection.280 Due to the wide availability of flow
cytometers in clinical settings, they possess the capability of quick and
reproducible detection of exosomes for diagnosis.
The Biogenesis of Exosomes
To date, two distinct mechanisms are involved in the biogenesis of
exosomes. The first one depends on the endosomal sorting complex required for
transport (ESCRT) function.281 Different subsets of ESCRTs, such as ESCRT-0,
ESCRT-I, ESCRT-II, and ESCRT-III are involved in the process of exosome
formation.282 ESCRT-0 recognizes and leads the cytoplasmic proteins to the
specific domain of the endosomal membrane before interacting with ESCRTI/ESCRT-II complex to initiate the multi-vesicular bodies (MVB) formation with
ESCRT-III that promote the development of budding. Finally, ATPase VPS4
protein promotes the membrane scission to release exosomes.282 However,
several studies with depletion of subsets of ESCRTs could not totally block the
production of exosomes.283,284 Alternative mechanism has been proposed, which
is based on lipid raft-related exosome segregation from the endosomal
membrane.285 Researchers observe that the depletion of sphingomyelinase,
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which regulates formation of ceramide, results in the reduction of proteolipid
protein via exosomes. However, replenishment of sphingomyelinase recovers the
production of exosomes. Additionally, the presence of ceramide is necessary for
the secretion of miRNAs in exosomes, which are ESCRT-independent.286
The Roles of Exosomes in the Endothelial Function
Exosomes targeting Endothelial Cells. Exosomes from other cells could
be uptaken by endothelial cells, which regulate the endothelial functions. It is
evident that miRNAs, one subset of non-coding RNAs, are involved in the
regulation of cellular processes.287 miRNAs, as key components of exosomes,
have been reported to modulate the various functions of endothelial cells. MiR92a secreted from leukemia cells, which decreases integrin α5 expression,
promotes cell migration and tube formation, but not angiogenesis in endothelial
cells via exosomes288, while miR-210 from hypoxic leukemia cells is also
observed to improve the tube formation of endothelial cells by downregulating
target gene (EFNA3).289 However, miR-320 in exosomes from diabetic or higherglucose treated cardiomyocytes impairs endothelial angiogenesis by
downregulating the target genes( IGF-1, Hsp20 and Ets2) in mouse cardiac
endothelial cells 290, and miR-125a in exosomes of mesenchymal stem cells is
capable of inhibiting the angiogenesis of endothelial cells by suppressing the
production of angiogenic inhibitor delta-like 4 (DLL4)291. Recently, long noncoding RNAs (lncRNAs), another subset of non-coding RNAs, have been
discovered to play roles in the physiological conditions292,293, and were observed
in exosomes294. CD90+ liver cancer cells secret exosomes with lncRNA H19 to
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affect VEGF and ICAM1 expression in endothelial cell and tube formation to
promote interaction between cancer cells and endothelial cells. 295
Moreover, exosomes modulate endothelial inflammatory responses too.
Macrophages under hypertensive condition could secret exosomes with
increased levels of CD68, a macrophage marker, and induce inflammatory
responses in endothelial cells with increased productions of ICAM and
plasminogen activator inhibitor-1 (PAI-1).296 Mast cell derived exosomes are also
able to activate endothelial inflammation by promoting PAI-1 expression in the
endothelial cells.297 Mature dendritic cell derived exosomes are reported to
activate NF-κB related inflammation in endothelial cells, triggered by TNF-α on
the membrane of exosomes.298
Exosomes from Endothelial Cells. Since there is wide distribution of
endothelial cells in the body, EVs from endothelial cells contribute to a large part
of circulating microparticles. 299 Exosomes from endothelial cells could target
both other cells and themselves to alter cell functions. In a co-culture system,
researchers found exosomes from endothelial cells, incubating with
cardiomyocytes for 45mins followed by ischemia/reperfusion stimulation, induced
cardioprotective function through the ERK1/2 MAPK signaling pathway, which
may partly explain the benefits of ischemic preconditioning (short, non-lethal
periods of ischemia and reperfusion to protect heart from subsequent ischemia
and reperfusion injury) induced higher level of exosomes from rat heart to
cardiomyocytes in vivo.242 MiR-214 in endothelial exosomes promotes
angiogenesis and migration of endothelial cells in vivo and in vitro with
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suppression of ataxia telangiectasia mutated (ATM) expression in recipient cells
nearby.300 Halkein et al reported 16-kDa prolactin increased miR-146a
expression in endothelial cells, which could be exported into exosomes captured
by cardiomyocytes and modify the metabolic situation of cardiomyocytes with
decreased expressions of Erbb4, Notch1, and Irak1.301 Endothelial cell derived
exosomes are involved in the regulation of functions of immune cells. Song et al
observed that exosomes carrying integrin αvβ6 from cardiac endothelial cells are
capable of stimulating active TGF-β expression in B cells, which display a
suppressive effect on the T cell proliferation.302 The immunomodulation by
exosomes from endothelial cells is discovered in monocytes, where miR-10a
translocases from endothelial cells into monocytes targeting several members of
the NF-κB signaling pathway to reduce inflammatory responses of monocytes in
vivo and in vitro.303 Furthermore, another group demonstrated endothelial cell
derived exosomes have ability to polarize macrophages into M2 state with antiinflammatory responses.304 The above information reminds us of the important
roles of exosomes from endothelial cells in the regulation of functions in other
cells.
The Roles of Exosomes in Inflammation
The contributions of exosomes in the regulation of inflammation are
diverse for their different sources and settings.
Anti-Inflammatory Roles of Exosomes. Exosomes from various cancer
cells have been reported to downregulate inflammatory responses of immune
cells. Clayton et al presented exosomes from different cancers, such as bladder,
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colorectal and prostate, present inhibitory functions on T cells, which are CD73 or
CD39 dependent.305 Exosomes from nasopharyngeal carcinoma (NPC) display
the capability to recruit Treg cells in mouse model and promote the conversion of
CD4+CD25- T cells into CD4+CD25+ cells with immunosuppressive functions to
bolster immune evasion.305 In addition, reduced cytotoxicity of NK cells are
induced by exosomes loading MICA*008 from Hela cells.306 Due to the
contributions of tumor-associated macrophages (TAMs) in tumor development,
recent study unveiled exosomes, derived from gastric cancer, educate a
generation of TAMs, which produce anti-inflammatory cytokines and dampen
function of CD8+ T cells with a result of gastric cancer progression and low
survival outcome of patients.307
Pro-Inflammatory Roles of Exosomes. Tumor derived HSP70/HSP90
have been observed in the circulation of cancer cachexia in mice. Both HSPs
could be released into exosomes from tumors and work as DAMPs to induce the
NF-κB signaling pathway by activating TLR4 on muscle cells.308 Increased levels
of HSP70 in exosomes from bronchoalveolar lavage fluid (BALF) of patients with
sarcoidosis could activate peripheral blood mononuclear cells (PBMCs), with
elevated IFN-γ and IL-13 production, and induce epithelial cells to produce more
IL-8, which indicate the pro-inflammatory roles of BALF exosomes in
sarcoidosis.307 Additionally, immunomodulatory miRs in the exosomes are
reported to modulate inflammation. MiR-21 and miR-29a in tumor-secreted
exosomes display pro-inflammatory regulation on the recipient immune cells by
binding TLR, such as human TLR8, to activate NF-κB signaling to produce
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prometastatic inflammatory cytokines.309 Induced production of exosomes from
hepatocytes treated with alcohol are reported in humans and in mice; and
increased levels of miR-122 in exosomes of alcohol-treated hepatocytes
sensitize monocytes to LPS stimulation with increased pro-inflammatory cytokine
production.310
The Roles of Exosomes in the Sepsis
Clinical observations show increased populations of plasma
exosomes311,312, and plasma exosomes during CLP sepsis, present smaller sizes
but higher numbers, compared with exosomes from sham mice313. Both clinical
research and basic studies indicate the important roles of exosomes in the
progress of sepsis. However, the specific contribution of exosomes in sepsis is
still debated. Exosomes from platelets in septic patients play important roles in
the development of cardiomyopathy dysfunction, where platelet-derived
exosomes contain NOS to boost production of NO in the myocardium. 314,315
Moreover, Essandoh et al reported that suppression of exosome generation by
its inhibitor, GW4869, could significantly improve survival outcome in CLP sepsis
mice and endotoxin mice with reduced inflammatory responses and alleviated
cardiac dysfunction caused by sepsis.316
On the contrary, Gao et al observed that exogenous exosomes from
septic mice improve survival outcome of septic mice with reduced immune
responses.317 Wang et al discovered the cardioprotective role of exosomes from
mesenchymal stem cells (MSCs) administrated in septic mice exhibiting
improved survival outcome requires miR-233 that is exported from MSCs
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downregulating expression of Sema3A and Stat3 in cardiomyocytes.318 MiR-146a
released from MSCs by exosomes has been reported to polarize macrophages
into an M2 state with attenuated septic death in mice.319 Miksa et al pointed out
that milk fat globule epidermal growth factor-factor VIII (MFG-E8) in exosomes
from bone marrow derived dendritic cells (BMDCs) alleviates sepsis-induced
death by reducing cell apoptosis and inflammatory responses. 320
The inverse functions of exosomes in sepsis indicate the complicated
mechanism of exosomes in the development of sepsis. One reasonable
explanation is that exogenous and endogenous sources of exosomes hold
different roles during sepsis.
The Potential of exosomes for the diagnosis and treatment of Sepsis
To date, there is no ideal biomarker for diagnosis of sepsis in the clinical
practice.321 Considering the alteration of components in exosomes from septic
patients, they have been regarded as potential biomarkers to diagnose and
predict the progress of sepsis. Septic animal experiments show increased levels
of serum miRNAs, such as miR-16, miR-17, miR-20a, miR-20b and miR-26a,
which present a time-dependent mode.322 Plus, there is a highly positive
relationship between specific miRNAs, such as miR-15a and miR-27a, and the
development of endothelial dysfunction in septic patients.323 However, further
studies are required to determine various miRNAs in exosomes to indicate the
different stages of sepsis. Aside from exosomes as biomarkers for sepsis,
exosomes, as drug carriers, are potential tools for the treatment of sepsis.
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Trained Immunity
Traditionally, the immune system consists of innate and adaptive immunity.
The specific characteristics of adaptive immunity are its immunological memory
and specificity for quick response to secondary stimulation, which is not found in
the innate immunity. However, mounting evidence indicates innate immune cells
can be trained such that they will exhibit immunological memory to secondary
stimulation, which is called trained immunity.
Discovery of Trained Immunity
Studies in Plants. Studies in the natural protection of plants revealed an
interesting phenomenon that plants possess resistance against a broad spectrum
of microorganisms after inoculating with weaken pathogens. This observation
called “systemic acquired resistance” (SAR), was published in 1933.324 Following
studies in the past decades lead us to conclude SAR in plants is the counterpart
of immunization in vertebrate and indicate plants have innate immune memory,
which is well summarized in several reviews.325,326
Studies in Invertebrates. Because of the deficit of the counterparts of
adaptive cells found in vertebrates in the invertebrate organisms, researchers are
interested in how they respond quickly to secondary stimulation without immune
memory. A reasonable explanation for this phenomenon is that there are other
mechanisms to execute immunological function. Thus, organisms in the
invertebrate kingdom provide ideal animal models to investigate whether there is
immunological memory in the innate immune responses for the secondary
challenge.327 Studies in Drosophila reveal a prolonged antimicrobial pattern after
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a pathogenic stimulation, and a broad spectrum of resistance to other secondary
infections present in several conditions.328–330 Pham et al showed that drosophila
with a sublethal dose of S. pneumoniae could resist to a following lethal
challenge, which is required for activation of the TLR signal pathway.330 Apart
from Drosophila, other invertebrates, such as shrimps and copepods, are also
found to possess immunological memory for secondary and heterogeneous
stimulations.331,332
Studies in Vertebrates. The existence of an immunological memory of
innate immunity in plants and invertebrates hints the possibility of innate immune
memory in vertebrates. In 1931, a report in Sweden was published that showns
the vaccines, Bacillus Calmette-Guerin (BCG), not only protect infants against
Mycobacterium tuberculosis (M. tuberculosis) but also produce unintended
results of decreasing death in infants.333 This reduction of mortality in infants with
BCG was also reported in the following years.334 Besides the off-targets of BCG
on infection, smallpox vaccines offer protection against leprosy.335 In animal
experiments, mice with BCG display resistance to secondary challenges with
Candida albicans (C. albicans) or Schistosoma mansoni. This resistance is
through a T cell–independent mechanism,336 but requires activation of tissue
macrophages337. Further experiments within athymic mice show that protection
against Staphylococcus aureus is induced in mice injected with attenuated
strains of C. albicans, which indicate this cross-protection is not a T celldependent mode.338 An unexpected experimental result in the Netea Lab records
monocytes, from donators vaccinated with BCG, against C. albicans infections by
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increasing expression of IL-1β and TNF. Further study demonstrates that β-1, 3(D)-glucan (β-glucan), a major cell wall component of C. albicans, contributes to
the non-specific protection of monocytes against secondary stimulation.339
Combining these results with other published researches about non-specific
adaptation of innate cells, Dr. Netea proposed a novel concept called “trained
immunity”, where innate immune cells could be trained with specific agents to
produce non-specific memory against secondary infections. This novel concept
has prompted scientists around the world to rethink the role of innate immunity.
Trained Immunity in Immune Cells
NK cells. NK cells are grouped as members of innate immunity, although
they work like CD8+ cytotoxic T cells, in adaptive immunity, and share a similar
feature in cytokine production.340 During an infection, T cells, classic adaptive
cells, undergo four phases: expansion phase341, contraction phase342, memory
maintenance phase343 and recall phase344, to complete a whole cycle of immune
response. There were only first two phases recognized in NK cells. However, in
2009, Sun et al reported that NK cells also have the ability to shape memory
about infection for a quick response to secondary challenge.345 In this study,
“memory” NK cells could even be detected at 70 days after infection, the cells
being activated by higher levels of IFN-γ transcripts than those found in naïve NK
cells. Neonatal mice without mature NK cells are transferred with naïve and
“memory” NK cells prior to infection. Neonates with “memory” NK cells present
significant improvement in survival compared to that in neonates given by naïve
NK cells. The following study by Dr. Netea group identifies BCG vaccination
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could induce trained immunity in NK cells with increased IL-1β, IL-6 and TNF
under M. tuberculosis stimulation. BCG vaccination significantly improves
survival outcome of SCID mice, which are partially NK cell dependent.346 An
excellent review by Cerwenka and colleagues summarizes the immunological
memory of NK cells in various pathological conditions.347
Innate Lymphoid Cells (ILCs). ILCs share the same lymphoid progenitors
with B cells and T cells, working analogous to CD4+ T helper cells, but respond
quickly to infection like innate immune cells and do not express antigen receptors
on T cells and B cells.348 Thus, ILCs have been regarded as intermediates or
bridges between innate immunity and adaptive immunity.349 When Halim et al
investigated the differentiation of Th2 cells under allergen stimulation, they
surprisingly found that ILC2s located in the lung produce cytokines, such as IL-5
and IL-13, and parts of the ILC2s, after allergy, stay on the lung and lymph
node.350 In 2016, further study from the same group demonstrates that allergenexperienced ILC2s are capable of memorizing the allergen to respond quickly to
a second one. Moreover, Aspergillus stimulated ILC2s with another papain
challenge 3.5 months later, displayed an increased population of IL-5+IL-13+
ILC2s in the lungs with mounting levels of IL-5 and IL-13, which indicate that nonspecific memory is built in ILC2s after stimulation.351
Monocytes/Macrophages. Although several studies about the role of
macrophages in acquired immunological memory have been published 30 years
ago337,338, this interesting feature of macrophages has not attracted enough
attention from other scientists. Not until Netea and colleagues published a series
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of papers about monocytes with non-specific memory, more related studies
emerge.352-353 Dr. Netea in 2011, for the first time, named immunological memory
of innate cells as “trained immunity”.333 His group was also the first to propose an
in-vitro model to test trained immunity in monocytes, where monocytes are
incubated with unlethal C. albicans for 24 hours, after resting for 6 days, prior to
any other stimulations, such as PRRs, ligands or bacteria, for 24 hours. This
study indicates that monocytes incubated with C. albicans or β-glucan could
markedly express pro-inflammatory cytokines, such as TNF-α and IL-6, in
monocytes with stimulation of TLR ligands, such as LPS, P3C and Pam3, later.
Training of monocytes is requiring activation of the dectin-1/ Raf-1 pathway,
whereby dectin-1 is the receptor of β-glucan on the monocytes.339 In the following
publication, research from Netea’s lab presents that BCG vaccination-induced
non-specific protection, in newborns facing other infections, is macrophagedependent.352 Apart from increased pro-inflammatory cytokine productions, from
peripheral blood mononuclear cells (PBMCs) vaccinated with BCG after various
pathogen challenges, these increased cytokine productions could be detected in
the PBMCs of volunteers with BCG vaccination after 3 months. Regulation of
monocytes by BCG is through NOD2, but not through TLRs or dectin-1.354
Further study indicates that BCG-induced metabolic, skewed towards glycolysis,
is essential for trained immunity in monocytes, which is regulated by the AktmTOR signaling pathway.353 Besides BCG primed trained immunity in monocytes,
β-glucan has been reported to contribute to induction of trained immunity in
monocytes. β-glucan pre-treated macrophages exhibit the protective function
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against L. braziliensis infection, with increased IL-6 and IL-10 productions, and βglucan-induced trained immunity is IL-32 dependent.355 Additionally, β-glucan
primed monocytes undergo a metabolic switch, where glycolysis, glutaminolysis
and cholesterol synthesis are crucial for the induction of trained immunity in
monocytes.356 β-glucan related glycolysis in monocytes is modulated by the
dectin1-Akt-mTOR-HIF-α signaling pathway, which is demonstrated by abrogated
trained immunity in monocytes from dectin-1 deficient patients.357 Moreover,
LPS-priming induced immunological tolerance could be partly reversed by βglucan in vivo and in vitro, whereby β-glucan-induced tolerant reversion in
monocytes is through modulation of transcriptional responses at epigenetic levels.
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Further study in Netea and colleagues showed that β-glucan reverses the

reduction of succinate dehydrogenase (SDH) in LPS-induced tolerance, which
contributes to trained immunity in monocytes. β-glucan induced trained immunity
enhances histone acetylation, to promote SDH production, by maintaining
metabolic status and boosting pro-inflammatory cytokine production in
monocytes.359 This demonstrates β-glucan in the regulation of
immunometabolism is essential for trained immunity in monocytes against LPSinduced tolerance.
Trained Immunity in Non-Immune Cells
Stem Cells. Mesenchymal stem cells(MSCs) could work like immune cells,
which express TLRs360 and produce pro-inflammatory cytokines, or antiinflammatory cytokines, in distinct settings 361. Liu et al, for the first time, report
trained immunity in MSCs.362 In their study, adipose-derived MSCs (AD-MSCs),
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stimulated with LPS or TNF-α, display increased expression of MCP-1, IL-8 and
IL-6, as well as quick cytokine expression, in the secondary stimulation.
Interestingly, LPS primed AD-MSCs show better therapeutic effect on skin flap
survival in diabetic rats than the counterpart in rats with unprimed AD-MSCs.
However, the time range of immunological memory shown in AD-MSCs is just 7
days, while the trained immunity in monocytes could persist for several months
and even years.362,363 Moreover, Kanfmann et al observed an interesting
phenomena, that BCG vaccine could arrive in bone marrow and persist for
several months, and that BCG trained hematopoietic stem cells (HSCs) prefer to
polarize towards myeloid lineage, to generate trained monocytes/macrophages,
with increased pro-inflammatory cytokine production against M. tuberculosis
infection.364 Since the life span of circulating monocytes is relatively short, and
monocytes are differentiated from bone marrow, Kanfmann’s findings well may
explain why immunological memory in monocytes could persist for months and
even years. Additionally, Mitroulis et al reported that β-glucan, a trained immunity
agonist, could promote myelopoiesis with increased populations of hematopoietic
progenitors (LSKs) and multipotent progenitors (MPPs) in bone marrow.
Increased MPPs stimulated by β-glucan exhibit a switch toward the myeloid
subset. Mice challenged with LPS 28 days prior to β-glucan administration
display markedly increased hematopoietic progenitor expansion, including LSKs
and MPPs with reducing LPS-induced DNA damage. β-glucan related protection
also relieves chemotherapy-induced myelosuppression with increased numbers
of white blood cells and granulocytes in the circulation.365
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Fibroblasts. Fibroblasts are widely distributed in all tissues and exhibit
various morphologies with different functions, such as contractility366,
locomotion367, collagen production368, and regulation of the extracellular matrix368.
Interestingly, fibroblasts are also reported to be involved in the regulation of
inflammation, whereby they serve as sentinels, to modulate leucocyte
extravasation by releasing cytokines in pathological conditions.369,370 In addition,
fibroblasts express all TLRs and produce pro-inflammatory cytokines and
chemokines.371 Fibroblasts can be considered as immune-like cells, to some
extent. Several publications point out that fibroblasts possess immunological-like
memory. Ara et al, while investigating periodontal disease, found that gingival
fibroblasts could persist to produce pro-inflammatory cytokines with successive
LPS challenges for 7 days, whereas macrophages undergo LPS tolerance.372
Moreover, fibroblasts in tendinopathy exhibit a feature of persistent activation 2-4
years after treatments, and produce more activated markers under IL-1β restimulation, with increased IL-6 and IL-8 productions, compared with the
counterpart from fibroblasts of healthy donators.373 In condition of rheumatoid
arthritis (RA), Fibroblast-like synoviocytes (FLS) exposed to TNF-α pretreatment
for 3 days are more sensitive to secondary IFN-β or IFN-γ stimulation with 1 day
gap with increased cxcl-10 expression. This inflammatory activation could be
sustained even the gap time is extended to 3 days.374 The same group also
found that the memory feature of FLS from joints in both RA and healthy patients,
which indicate the immunological memory in FLS is induced and may play an
important role in the development of chronic joint diseases.375

60

Epithelial Cells. Like fibroblasts, epithelial cells express most TLRs, and
work as an interface between the external and internal milieu and fight as a first
line to external invading pathogens or other stimulations376. The important role of
epithelial cells in the regulation of immune responses have been reviewed in
these publications.377–380 Currently, bronchial epithelial cells (BECs) display the
memory feature against non-specific infections. Bigot et al performed
experiments by utilizing BECs incubating with different PAMPs, such as flagellin,
Pam3 and lipopeptide for 2 days followed 4 day resting prior to other PAMPs,
including LPS, A. fumigatus and S. maltophilia respectively. BECs pre-stimulated
with flagellin present increased levels in IL-6 and IL-8 expression with an A.
fumigatus challenge, which exhibits a broad protection of BECs under different
stimulation. However, BECs pre-stimulated with flagellin could display a tolerant
situation, when re-stimulated by LPS. The immunological characteristics of BECs
are related with epigenetic modification, which could be suppressed by inhibitors
of histone acetyltransferase or histone methylation.381 In addition, epithelial stem
cells (EpSCs), exhibit inflammatory memory to respond quickly to later challenge.
Naik and colleagues investigating how inflammation affect EpSCs, unexpectedly
observed that EpSCs triggered with NALP3 agonist (imiquimod, IMQ) display
features of faster wound healing after a secondary assault, whereas enhanced
wound healing could also be obtained by EpSCs with other pre-stimulations,
such as C. albicans (to induce infection), vitamin D analog MC903 (to mimic
atopic dermatitis) and 12-o-tetradecanoylphorbol 12- acetate (TPA) (to induce
hyperplasia). Further study demonstrates improved wound healing is
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macrophage-independent and T cell-independent, and inflammatory memory of
EpSCs is only restricted in the treatment area, not transmitted to other sites of
body382.
Mechanisms of Trained Immunity
Mechanism of Epigenetic Regulation. Epigenetic dynamics influence gene
expression and modify cellular functions without altering the DNA sequence,
such as DNA methylation, and histone modification. Environmental factors
(nutrients, toxins, infections and hypoxia) and pathological conditions contribute
to epigenetic modification, which is reversible and inheritable for multiple
generations of cells383,384. Gene expression is tightly controlled by the
cooperation among transcription factors (TFs) and several regulatory elements in
genes, such as promoters and enhancers.385 Epigenetics is an important factor in
the development of inflammatory responses in immune cells.386
DNA Methylation. DNA methylation occurs at a cytosine nucleotide,
forming 5-methylcytosine (5mc) immediately followed by a guanine nucleotide,
which is referred as 5’-cytosine-phosphate-guanine-3’ dinucleotide (CpGs). CpGs
forms CpG islands, mostly located in the promoter of a gene transcription start
site, which is associated with gene suppression.387 On the one hand, 5mc is
identified by CpG-binding proteins, which recruit other transcriptional repressors
on the CpG in the promoters to silence gene expression at transcriptional
levels.388 On the other hand, 5mc could occur at other regulatory elements, such
as enhancers and insulators, also be involved in the transcription elongation and
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alternative slicing.389 Current studies indicate that DNA methylation in different
pathological conditions influence macrophage polarization.390,391
Histone Acetylation. Nucleosome, as the basic unit of chromatin, consists
of 146 bp DNA sequence and octameric core histones that are composed of two
H3 and H4 homodimers and two H2A/H2B heterodimers.392 Unpackaged tails of
H3 and H4 histones from the nucleosome could be modified to affect the
interaction between DNA and histone proteins for transcriptional
activation/inactivation.393 Among the variety of histone modifications, acetylation
at lysines (K), methylation at lysines (K) and arginines (R), have been widely
investigated.394 Histone acetylation is regulated by two distinct groups of
enzymes, with histone acetyltransferases (HATs) contributing to the transfer of
an acetyl group to histone lysine tails, and the histone deacetylases (HDACs),
which lead to the removal of acetyl groups from histone lysine tails.393 The
detailed functions of HATs and HDACs are summarized in these reviews.395,396
The acetyl groups added on lysine residues of histone tails, neutralize the
positive charges of histones, which results in weak binding between histone and
DNA and also the subsequent allowance of transcription.393 Current studies have
identified that K 9, 14, 18, 23 and 56 on histone H3 could be acetylated, and
acetylation of K9397,398 and K27399 (H3K9ac and H3K27ac) are usually related
with enhancers and promotors of active genes.
Histone Methylation. Compared with acetylation on histones, the
occurrences of methylation on histones are more complicated. Although histone
methylation does not influence the state of charge of the histone proteins, the
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different residues that are added by methyl groups, and the numbers of
transferred methyl groups, could determine the status of transcriptional
suppression or activation.400 For example, mono-methylation at K 20 of histone
H4 (H4K20me) is associated with gene activation401, while tri-methylation at K 20
of histone H4 (H4K20me3) at the promoters of gene represses gene activation402.
H3K4me and H3K4me3 are primarily located in enhancers and promoters
separately.403 H3K9me3 are reported with, either gene activation in cancers,404 or
gene suppression in stem cells405. Current studies indicate the important role of
histone methylation in inflammation.386,406,407 Histone methylation is regulated by
two distinct groups of enzymes, whereby histone methyltransferases (KMTs)
contribute to the transfer of methyl groups to histone lysine tails and histone
demethylases (KDMs) lead to the removal of methyl groups from histone lysine
tails. Detailed information about KMTs and KDMs is summarized by these
publications.408,409
Mechanism of Epigenetic Regulation in Trained Immunity. Although
induction of trained immunity in different cell types is associated with persistent
epigenetic modifications, epigenetic profiling in the trained immunity of
macrophages/monocytes has been relatively more investigated.354,381,358 Here,
we just focus on the introduction of macrophages/monocytes related epigenetic
regulation in trained immunity. Chip-seq assay indicates a globally increased
level of H3K4me3 in peritoneal macrophages 7 days after C. albicans primed
mice, but β-glucan induced the change of H3K4me3, observed after 7 days,
appears after 24 hours of β-glucan training human monocytes. Moreover,
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enhanced H3K4me3 at the promoters of proinflammatory cytokines, such as
TNF-α, IL-6 and IL-8, displays in the β-glucan training monocytes.339 Plus, BCGinduced nonspecific protection from secondary infection is monocyte-dependent,
and evaluated H3K4me3 is still maintained at promoters of TLR4, IL-1β and TNFα, in peripheral blood mononuclear cells (PBMCs), 3 months after BCG
vaccination.354 BCG priming BMDMs also present significantly gains in
H3K27me3 and H3K27ac at promoters of immunological genes against M.
tuberculosis infection.364
LPS-induced tolerance in monocytes (refractory state) displays distinct
functions within β-glucan-induced trained immunity in monocytes (sensitive
responsive state), which possess different epigenetic profiles. β-glucan priming
monocytes show higher marked H3K27ac at all promoters and enhancers,
whereas LPS induces persistent H3K4me but not HEK27ac marking enhancers,
which accounts for the tolerant feature.410 LPS priming macrophages present
marked H3K4me enhancers, different from β-glucan priming macrophages. RNAseq assay indicates that β-glucan contributes to phagocytosis and the cytokine
release of monocytes, but that LPS exposure suppresses their activation. Further
study unveils that re-exposure of β-glucan could reverse LPS-induced tolerance
in monocytes by restoring H3K27ac marking promoters and enhancers of genes
related to metabolism and lipid biosynthesis.358
Unlike the wide investigation of histone epigenetic regulation for trained
immunity, much less has been reported of the contribution of DNA methylation in
trained immunity. Although DNA methylation has been reported in monocyte-to65

macrophage differentiation with the loss of DNA methylation, no change in DNA
methylation presents in trained macrophages. However, specific stable DNA
methylation patterns occur in LPS priming macrophages, which provide a
potential biomarker for immune-tolerance caused by LPS.358
Role of Trained Immunity in Sepsis
Sepsis-induced tolerance of innate immune cells results in an
immunosuppressive state in patients, which puts them at tremendous risk of any
opportunistic infections and increases the chance of mortality.411 Sepsis-induced
immunosuppression is positively related with activity of HDACs412, and autopsies
of septic patient’s brains present increased expression of the HDAC6413. Current
studies unveil the role of β-glucan in the activation of histone acetylation.414,415 βglucan-induced trained immunity in monocytes comes with increased H3K27ac
modifications, which are also broadly distributed in inflammatory genes.357,356,416
β-glucan not only induces memory in monocytes for a quick response to
secondary non-specific challenges by histone acetylation357, but also reverses
LPS-caused tolerance in monocytes, by restoring H3K27ac deposition358, both of
which indicate the potential role of trained immunity in the treatment of sepsisinduced tolerance through the regulation of the epigenetics of histones. Indeed,
research from Dr. Netea’s lab has demonstrated that β-glucan trained septic
mice display significantly decreased mortality compared with normal septic
mice.357
In our current research, efforts are directed at understanding the role of
endothelial exosomes, carrying HSPA12B, in cardiac function after sepsis. We
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are also interested in the mechanism by which β-glucan, as a stimulator of
trained immunity, induce protection in CLP sepsis. Herein, we test the role of
endothelial HSPA12B in β-glucan induced trained immunity in CLP sepsis.
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CHAPTER 2. HSPA12B ATTNEUATES CARDIAC DYSFUNCTION BY
REGUALTION OF NF-κB SIGNALING PATHWAY IN ENDOTHELIAL CELLS IN
POLYMICROBIAL SEPSIS

Introduction
Sepsis is recently defined as the life-threatening organ dysfunction caused
by a dysregulated host response to infection.7 Since the first defense line of
endothelium against infection, PRRs on endothelial cells could recognize PAMPs
to activate endothelial cells for recruitment of immune cells, eradicating invading
microorganisms, which regain physiological equilibrium in the normal
situation.68However, endothelial cell activation in sepsis plays an important role in
cardiac dysfunction, which contributes largely to the mortality of severe septic
patients.417,418 Activation of endothelial cells during the pathogenesis of sepsis
could express adhesion molecules, such as ICAM1 and VCAM1, to assist
immune cells, including innate cells and adaptive cells, to anchor themselves and
ultimately transmigrating through endothelium into tissues, the result of which is
tissue damage by cytokine storm from immune cells.419,50
Dr. Han and his colleagues discovered and demonstrated that HSPA12B
is a member of HSP70, which predominately expresses in endothelial cells. 110,111
This specific expression pattern indicates the role of HSPA12B in regulating the
functions of endothelial cells. In the following studies, Dr. Liu’s lab has done
excellent work in unveiling the contributions of HSPA12B in different
pathophysiological conditions. Their studies have proven that HSPA12B could
attenuate MI, or endotoxin-induced cardiac dysfunction, by downregulating the
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infiltration of immune cells, with reduced adhesion molecule expression in
myocardium.420,421 Moreover, their studies found that HSPA12B could prevent
LPS-induced inflammatory responses in the endothelial cells by inhibiting
activation of PI3K/Akt signaling pathway. However, the mechanism of HSPA12B
regulating adhesion molecule expression that modulates immune cell infiltration
in CLP sepsis is still unclear.
The NF-B signaling pathway is widely known to regulate the activation of
innate immune cells. For instance, TLR4 on the members of immune cells binds
with LPS/endotoxin activating several kinases to induce phosphorylation of I-B
for degradation and then releases NF-κB dimers in the cytoplasm, then
translocating into the nucleus, finally activating down-stream gene expression.422
However, the functions of The NF-B signaling pathway are not just restricted to
the regulation of inflammatory responses. Past research has demonstrated the
role of the NF-B signal pathway in the regulation of adhesion molecule
expression, such as ICAM1 and VCAM1, in endothelial cells.423,424 Furthermore,
the protective role of HSPA12B requires activation of the PI3K/Akt signaling
pathway425,113,114, which has been reported to negatively regulate NF-B binding
activity.426–428
In this study, we hypothesize that endothelial HSPA12B plays a role in the
downregulation of NF-B signal pathway, contributing to reduced adhesion
molecule expression in endothelial cells. Our results show that HSP12B
deficiency significantly induced server septic mortality with worse cardiac function

69

and increased adhesion molecule expression in the myocardium. And HSPA12B
can downregulate NF-B signal pathway with reduced adhesion molecule in the
endothelial cells.
Materials and Methods
Animals
Endothelial specific HSPA12B knockout mice (HSPA12B-/-) were
generated by cross-breeding the conditionally targeted HSPA12B mice with
C57BL/6. Cg-Tg (Tek-cre) strain which carries Cre recombinase under the
control of the Tek promoter. HSPA12B-/- mice and age matched wild type (WT)
C57BL/6 mice were used for experiments. The mice were maintained in the
Division of Laboratory Animal Resources at East Tennessee State
University. The experiments outlined in this manuscript conform to the Guide for
the Care and Use of Laboratory Animals published by the National Institutes of
Health (8th edition, 2011). The animal care and experimental protocols were
approved by the Eastern Tennessee State University Committee on Animal Care.
Cecal Ligation Sepsis Model
Murine polymicrobial sepsis was induced by cecal ligation and puncture as
described previously429,365,47,75. To induce a septic model, mice were
anesthetized by 5.0% isoflurane. A midline incision was made on the anterior
abdomen and the cecum was exposed and 1/3 of cecum was ligated with a 4-0
suture. One puncture was made at the end of cecum with a 23-gauge needle and
feces were extruded from the hole. The abdomen was then closed in 2 layers.
Sham surgically operated mice served as sham control. Immediately following
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surgery, a single dose of resuscitative fluid (lactated Ringer’s solution, 50 mL/kg
body weight) was administered by subcutaneous injection.
Echocardiography
Transthoracic 2-dimensional M-mode echocardiogram and pulsed wave
Doppler spectral tracings (Toshiba Aplio 80 Imaging System, Tochigi, Japan)
were used to measure left ventricular (LV) wall thickness, LV end-systolic
diameter, and LV end-diastolic diameter. Percentage of fractional shortening
(%FS) and ejection fraction (EF%) were calculated as described
previously47,75,429.
Immunofluorescent Staining
The procedure of the immunofluorescent staining was modified based on
the protocol provided by Cell Signaling Technology. Briefly, heart tissue was
harvested from septic mice for paraffin embedding. Paraffin embedded heart
blocks were sectioned at 5μm. Paraffin embedded sections were deparaffinized
and rehydrated by xylene three times for 5 min each, 100% ethanol twice for 5
min each, 95% ethanol twice for 5 min each, 75% ethanol once for 5 mins, 50%
ethanol once for 5 min and ddH2O once for 5 min. 10% goat serum was used to
block sections for 60 min at room temperature followed primary antibodies at 4 oC
overnight. At the second day, sections were washed by wash buffer (1xPBS) for
5 min three time each followed by fluorochrome-conjugated secondary antibody
for 60 min at room temperature in the dark. Sections were washed by wash
buffer for 5 min three times each followed nuclear staining by DAPI. Sections
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were finally washed by wash buffer for 5 mins three times each followed anti-fade
reagent for microscope examination.
Immunohistochemistry Staining
The procedure of the immunofluorescent staining was modified based on
the protocol provided by Cell Signaling Technology. Briefly, heart tissue was
harvested from septic mice for paraffin embedding. Paraffin embedded heart
blocks were sectioned at 5μm. Paraffin embedded sections were deparaffinized
and rehydrated by xylene three times for 5 min each, 100% ethanol twice for 5
min each, 95% ethanol twice for 5 min each, 75% ethanol once for 5 mins, 50%
ethanol once for 5 min and ddH2O once for 5 min. Antigen unmasking worked
with 10mM sodium citrate buffer with sections for 10mins at 95 oC and then
cooled sections for 30 min. 3% hydrogen peroxide was incubated with sections
for 10mins followed wash buffer (1x PBS) 5 min three times each. 10% goat
serum was used to block sections for 60 min at room temperature followed
primary antibodies (HSPA12B,1:100,Santa Cruz; CD31, 1:100, BD Pharmingen)
at 4 oC overnight. At the second day, sections were washed by wash buffer for 5
min three time each followed by biotinylated secondary antibody for 90 min.
Sections were washed by wash buffer 5 mins three times each by AB enzyme
reagent (avidin mixed with biotinylated HRP) for 30 mins. Sections were washed
by wash buffer 5 min three times each by peroxidase substrate for 30s to 10 min
and were checked staining under a microscope.
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ELISA for Organ Injury Assay
The serum levels of aspartate aminotransferase (AST, hepatic injury
marker) and creatinine (kidney injury marker) were measured with commercially
available kits according to the instructions provided by the manufacturer
(Millipore Sigma).
Genotyping
The procedure of genotyping was based on the HOTSHOT method.430
Briefly, 1 to 2 mm mice tail was removed and placed in a 500ul Eppendorf tube
and digested with 50ul Alkaline Lysis Reagent (25mM NaOH, 0.2mM EDTA, pH
12.0) at 95 oC for 30mins and chilled on ice followed by 50ul Neutralization
Reagent (40 mM Tris-HCl at pH 5.0) for DNA analysis. Genotypes of tissue
specific deletion in mice were analyzed with primers of floxd allele (HSPA12Bcko-1: 5’-GAAGCAAGCATATTCATCTCATTACTATTC-3’; HSPA12B-cko-2: 5’GCTTGCTCAAAAGTGATGGTTGCTC-3’. 191bp for flox mice; 151bp for wild
type mice), HSPA12B-/- (HSPA12B-cko-1: 5’GAAGCAAGCATATTCATCTCATTACTATTC-3’; HSPA12B-cko-4: 5’TAAAGCCTACACTCAGATGAGAGCAG-3’. 240bp for HSPA12B-/-, >2kb or no
band for wild type control) and Cre expression (5’
GTGAAACAGCATTGCTGTCACTT-3’ and 5’GCGGTCTGGCAGTAAAAACTATC-3’) for PCR, which was run in agarose gel at
60 volts and 110 milliamps followed taking picture with G-box.

73

Real-time PCR
Cell medium were removed, and cells were lysed with RNAzol@ RT by
pipetting several times to ensure complete lysis. Add 0.4ml DEPC water into
homogenate/lysate per 1ml RNAzol@ RT for homogenization followed by
shaking well and standing for 10mins. Centrifuge at 12000g for 15mins to move
1ml supernatant to a new tube and precipitate RNA by adding 0.4ml 75% ethanol,
waiting 10min followed 12000g for 8mins. Wash pellets (mRNAs) by 75% ethanol
twice at 8000g for 3 mins each. DEPC water dissolved pellets for cDNA reverse
transcription. cDNA was used for real-time PCR.
In vitro Experiments
Human umbilical vein endothelial cells (HUVECs) were cultured in
vascular cell basal medium supplemented with endothelial cell growth kits
(ATCC). After reaching 70%–80% confluence, HUVECs were transfected with
adenovirus expressing HSPA12B (Ad-HSPA12B-GFP) or adenovirus expressing
GFP. Six hours after transfection, the cells were washed and incubated with
fresh medium overnight followed by LPS stimulation for four hours. The cells
were harvested and the cellular proteins were prepared for Western blot431,118.
Western Blot
Western blot was performed as described previously47,75,432,433. In brief,
cellular proteins were separated by sodium dodecyl sulphate–polyacrylamide gel
electrophoresis and transferred onto Hybond enhanced chemiluminescence
(ECL) membranes (Amersham Pharmacia, Piscataway, New Jersey). The ECL
membranes were incubated with the appropriate primary antibodies followed by
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peroxidase-conjugated secondary antibody, which was purchased from Cell
Signaling Technology, Inc. The signals were quantified using the G: Box gel
imaging system by Syngene (Frederick, Maryland).
Statistical Analysis
The data are expressed as mean ± standard error. Comparisons of data
between groups were made using one-way analysis of variance (ANOVA), and
Tukey procedure for multiple-range tests was performed. The log-rank test was
used to compare group survival trends. Probability levels of ≤.05 were used to
indicate statistical significance.
Results
Construction of Endothelial Specific HPSA12B Knockout Mice
The current evidence indicates the protective role of HSPA12B in many
pathophysiological processes, including endotoxin-induced sepsis113, myocardial
infarction420, and stroke117. Thus, in our project, we investigated the function of
HSPA12B in polymicrobial sepsis. First, endothelial specifically deficient
HSPA12B mice were constructed by crossbreeding between Tek-Cre mice and
flox-HSPA12B mice shown in Figure1-3.

75

Figure 1. Development of endothelial HSPA12B specific deficient mice. A) The
depletion of HSPA12B is detected by PCR, by using three primers of Tek-Cre,
flox(HSPA12B-cko-1 and HSPA12B-cko-2) and HSPA12B-/-(HSPA12B-cko-1 and
HSPA12B-cko-4). B) The expression of HSPA12B in the myocardium is
examined by WB. β-actin serves as loading control. No band in HSPA12B-/group indicates the successful depletion of HSPA12B.
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Figure 2. The successful depletion of HSPA12B in endothelial cells of
myocardium. A) The distribution of HSPA12B is tested by immunofluorescent
staining. HSPA12B (green) are overlapped with CD31 (red), which is a marker of
endothelial cells in the myocardium of WT and HSPA12B-/- mice. (n=3/group); B)
The distribution of HSPA12B in the myocardium is also tested by
immunohistochemistry staining, which brown colors indicating HSPA12B are in
the endothelial cells of cardiac capillaries. n=3/group

Endothelial HSPA12B Deficiency Exacerbate Survival Outcome with Severe
Cardiac Dysfunction in Polymicrobial Sepsis
Due to the critical role of endothelium in the development of sepsis, we
investigated the effect of endothelial HSPA12B on the survival outcome in a CLP
septic model in mice. As shown in Figure 3, HSPA12B-/- septic mice exhibited an
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exacerbation of mortality compared with WT septic mice. The time to 100%
mortality of HSPA12B-/- septic mice was 163 hours, while the mortality to 62% of
WT septic mice was 200 hours after induction of CLP sepsis. The data suggests
that endothelial cell HSPA12B could play a protective role in limiting mortality of
CLP sepsis. Sepsis induced cardiomyopathy contributes to mortality and mobility
of sepsis434. We measured cardiac function during CLP sepsis. As shown in
Figures 4, cardiac function was not reduced at 6 hours after induction of CLP
sepsis. However, ejection fraction (EF%) and fractional shortening (FS%) were
both markedly reduced in both WT and HSPA12B-/- septic mice 24 and 36 hours
after CLP sepsis, when compared with their respective sham controls.
Importantly, the values of EF% and FS% in HSPA12B-/- septic mice were
markedly lower (12.1% and 19% at 24 hours, 6.1% and 15.1% at 36 hours) than
in WT septic mice. In addition, the serum levels of AST and creatinine kinase in
the HSPA12B-/- septic mice were significantly greater by 17.5% and 22.2% than
in WT septic mice (Fig.5). The data suggests that endothelial HSPA12B could
play an important role in the protection against sepsis induced organ injury.
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Figure 3. Increased mortality in HSPA12B-/- septic mice. WT and HSPA12B-/mice were subjected to CLP sepsis. The survival outcome was monitored for 200
hours following induction of CLP (n=21~27/group). All HSPA12B-/- septic mice
were died, however, which nearly 40% WT septic mice still survived at the
observing end point. ***P < 0.001 compared with indicated groups.
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Figure 4. More severe cardiac dysfunction in HSPA12B-/- septic mice. A-F)
Cardiac function was examined by echocardiography at 6, 24 and 36 hours after
CLP. EF%: Ejection fraction (%EF). %FS: Fractional shortening. (n=3~6/group)
*P < .05, **P < 0.01, and ***P < 0.001 compared with indicated groups.

Figure 5. Worse organ injuries in HSPA12B-/- septic mice. A-B) Serum levels of
aspartate aminotransferase (AST; A) indicating liver injury, creatinine indicating
kidney injury (B) were measured by commercially available enzyme-linked
immunosorbent assay kits. n=3~6/group. *P < .05, **P < 0.01, and ***P < 0.001
compared with indicated groups.
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Endothelial HSPA12B Deficiency Increases Adhesion Molecule Expression in
Polymicrobial Sepsis
An increased population of immune cells in the myocardium contributes to
septic cardiomyopathy435,46, whereby adhesion molecules expressed by
endothelial cells facilitate immune cell accumulation in the heart tissue.436 As
shown in Figure 6, the levels of VCAM-1 and ICAM-1 in the myocardium of
HSPA12B-/- septic mice were significantly greater than in WT septic mice. The
data indicates that endothelial HSPA12B could suppress myocardial adhesion
molecule expression, contributing to attenuation of immune cells (including
macrophages, and neutrophils) infiltration into the myocardium during sepsis.

Figure 6. Worse organ injuries in HSPA12B-/- septic mice. Western blot analysis
presented markedly increased levels of VCAM-1 and ICAM-1 in the myocardium
of HSPA12B-/- mice 36 hours after CLP sepsis, compared with WT septic mice.
(n=3/group). *P < .05, **P < 0.01, and ***P < 0.001 compared with indicated
groups. WS, WC, HS and HC indicate WT/SHAM, WT/CLP, HSP12B-/-/SHAM,
and HSP12B-/-/CLP separately.
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HSPA12B Overexpression in Endothelial Cells Decreases LPS-Induced
Adhesion Molecule Expression in vitro
To define how HSPA12B regulates adhesion molecule expression in
endothelial cells, we transfected endothelial cells (HUVECs) with adenovirus
expressing HSPA12B (Ad-HSPA12B-GFP) or Ad-GFP which served as vector
control. As shown in Figure 7A, HUVECs are successfully transfected with AdHSPA12B-GFP or Ad-GFP, indicated by GFP expression. The qPCR result
(Fig.7B) presents significantly higher expression in HUVECs transfected with AdHSPA12B-GFP, but not in control groups. Figure8 shows that HSPA12B
markedly suppresses ICAM1 (Fig.8A) and VCAM1 (Fig.8B) expression in LPSstimulated endothelial cells, which further demonstrate the role of HSPA12B in
the regulation of adhesion molecule expression in endothelial cells.
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Figure 7. Overexpression of HSPA12B in endothelial cells in vitro. A)
Immunofluorescent analysis of HSPA12B overexpression in HUVECs labeled by
GFP, and Ad-GFP which served as vector control. B) qPCR analysis displayed
significantly higher expression of HSPA12B in HUVECs transfected with AdHSPA12B-GFP, but not in control groups. (n=4/group) *P < .05, **P < 0.01, and
***P < 0.001 compared with indicated groups.
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Figure 8. Downregulation of HSPA12B in adhesion molecule expression in LPSstimulated endothelial cells in vitro. A, B) HUVECs were transfected with AdHSPA12B-GFP and Ad-GFP separately for 6 hours followed with fresh medium
change, resting overnight. On the second day, LPS (0.1ug/ml) were used to
stimulate HUVECs for 4 hours, then the levels of ICAM1 and VCAM1 were
evaluated by western blot. (n=3/group) *P < .05, compared with indicated groups.

HSPA12B Overexpression Downregulates NF-B Signaling Pathway in LPSStimulated Endothelial Cells
Due to the contribution of the NF-B signaling pathway in the regulation of
adhesion molecule expression in endothelial cells423,424, we further investigated
whether HSPA12B modulates the NF-κB signaling pathway in endothelial cells.
As shown in Figure 9, HPSA12B could prevent NF-κB P65 subunit, nuclear
translocation in LPS-stimulated endothelial cells. Moreover, HPSA12B
significantly suppressed phosphorylation of I-κB in the cytoplasm (Fig.10), which
inhibits P65 nuclear translocation to activate gene expression. The data suggests
that endothelial HSPA12B could play an important role in the protection against
sepsis induced increased levels of adhesion molecules.
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Figure 9. Suppression of HSPA12B in P65 nuclear translocation in LPSstimulated endothelial cells in vitro. HUVECs were transfected with AdHSPA12B-GFP and Ad-GFP separately for 6 hours followed with fresh medium
change, resting overnight. At second day, LPS (0.1ug/ml) were used to stimulate
HUVECs for 0.5 hours, then P65 nuclear translocation was evaluated by
immunofluorescent staining. Note: P65 nuclear translocation was inhibited by
HSPA12B in endothelial cells.
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Figure 10. Suppression of HSPA12B in phosphorylation of I-κB in the endothelial
cytoplasm LPS-stimulated cells in vitro. HUVECs were transfected with AdHSPA12B-GFP and Ad-GFP separately for 6 hours followed with fresh medium
change, resting overnight. At second day, LPS (0.1ug/ml) were used to stimulate
HUVECs for 0.5 hours, then phosphorylation of I-κB was evaluated by
immunofluorescent staining. Note: phosphorylation of I-κB was inhibited by
HSPA12B in endothelial cells. (n=3/group) *P < .05, **P < 0.01, and ***P < 0.001
compared with indicated groups.
Discussion
The present data demonstrates that endothelial HSPA12B exerts a
protective role on sepsis induced cardiac cardiomyopathy and mortality. The
mechanisms involve in the regulation of adhesion molecules in endothelial cells,
which are the key regulators to assist immune cell infiltration. Our data suggests
HSPA12B may downregulate the NF-κB signaling pathway, contributing to
decreased levels of adhesion molecules on endothelial cells.
Endothelial HSPA12B has been reported to prevent multiple organ
damage in different pathophysiological conditions, such as endotoxemia 437,
cardiac injury425 and stroke114.The mechanism is involved in the activation of
PI3K/Akt signaling.114,425 Overexpression of endothelial HSPA12B has been
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reported to prevent LPS-induced increased levels of adhesion molecules with
less neutrophil infiltration, in the lung of LPS-challenged mice.437 In our present
study, we found the deficiency of HSPA12B in the endothelial cells results in
more severe cardiac dysfunction with increased mortality, in polymicribial sepsis.
These findings provide evidence that endothelial HSPA12B may play an
important role in the regulation of expressions of adhesion molecule in the
myocardium, contributing to immune cell infiltration during sepsis.
To elucidate the mechanisms by which endothelial HSPA12B attenuates
sepsis induced cardiomyopathy and organ injury, we focused on the role of
endothelial HSPA12B in the regulation of adhesion molecule expression to
sepsis. Past research has demonstrated the contribution of adhesion molecule
expression in sepsis induced organ dysfunction in the clinical settings.438,78 We
found that endothelial HSPA12B deficiency results in increased expression of
ICAM1 and VCAM1, in the myocardium, during CLP sepsis. Interestingly,
overexpressing HSPA12B in the endothelial cells can significantly decrease LPSinduced upregulation of ICAM1 and VCAM1 in vitro. The in vitro and in vivo data
directly demonstrated the regulation of endothelial HSPA12B on adhesion
molecule expression.
Activation of the NF-κB signaling pathway has been reported to contribute
to sepsis-induced mortality and organ dysfuntions439. In our previous studies, we
have demonstrated that TLR-associated the NF-κB signaling pathway plays a
significant role in sepsis-related mortality440 and cardiac dysfunction47. To
elucidate the mechanisms by which endothelial HSPA12B modulates adhesion
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molecule expression in endothelial cells, we measured the role of the NF-κB
signaling pathway on adhesion molecule expressions in endothelial cells. We
found that HSPA12B significantly suppresses IB phosphorylation in LPSinduced endothelial cells, assisting NF-B P65 subunit nuclear translocation in
LPS stimulated endothelial cells, which is also confirmed by the immunostaining
results. Our data suggests that endothelial HSPA12B regulates the NF-B
activation in endothelial cells. Further studies are needed to investigate the
specific mechanisms by which HSPA12B suppresses IB phosphorylation in
the NF-B signaling pathway in endothelial cells.
Our results have indicated that HSPA12B prevents CLP-induced cardiac
dysfunction, partly through suppression of NF-B activation in endothelial cells.
Targeting HPSA12B could be an effective approach for treatment of cardiac
dysfunction in septic patients.
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CHAPTER 3. ENDOTHELIAL HSPA12B REGULATES MACROPHAGE
INFLAMMATORY RESPONSES VIA EXOSOMES SECRETION IN
POLYMICROBIAL SEPSIS

Introduction
In the United States, over 166,500 cases of sepsis occur yearly with a
mortality rate up to 50%441. Sepsis induced dysregulated immune responses play
a critical role in cardiovascular dysfunction, which is a major complication
associated with increased mortality in sepsis.442 Cardiac dysfunction in
sepsis/septic shock is associated with mortality rates as high as 70%.443
Endothelial cell dysfunction contributes to sepsis induced mortality and
organ dysfunction49. Heat shock protein A12B (HSPA12B) is a member of
HSP70 family and is predominately expressed in endothelial cells110. Previous
studies have shown that transgenic mice with endothelial cell specific
overexpression of HSPA12B exhibits a protection against endotoxemia or
myocardial ischemia induced cardiac dysfunction115. Increased expressing of
HSPA12B in endothelial cells attenuates LPS-induced adhesion molecules
expression and pro-inflammatory cytokine production via activation of the
PI3K/Akt signaling118. These data indicate that endothelial cell HSPA12B may be
an endogenous mechanism that serves to protect the host during sepsis.
Macrophages play a critical role in mediating innate immune and
inflammatory responses to sepsis challenge444,445. Increasing evidence
demonstrates that macrophages play different roles during different stages of
sepsis via the regulation of innate immune and inflammatory responses 445. In
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general, macrophage polarization has been divided into two groups, i.e. M1 proinflammatory and M2 anti-inflammatory phenotypes446. In the early stage of
sepsis, macrophages polarize toward the M1 phenotype, resulting in production
of pro-inflammatory cytokines446. In the late stage of sepsis, however,
macrophages frequently exhibit an M2 phenotype that regulates antiinflammatory mediators447. However, these heterogeneous functions of
macrophages are highly dependent on the microenvironment conditions165. The
role of endothelial HSPA12B in the regulation of macrophage inflammatory
responses during sepsis has not been fully elucidated.
Recent evidence suggests that there is a crosstalk between endothelial
cells and immune cells during sepsis448. Exosomes have been demonstrated to
play an important role in cell-cell communication449. Exosomes are one subset of
extracellular vehicles (EVs) that can be secreted from most cells450. Recent
studies have shown that exosomes are involved in the regulation of immune and
inflammatory responses451. Macrophage exosomes have been reported to alter
endothelial cell migration and inflammation452,296. However, whether endothelial
exosomes can regulate macrophage inflammatory responses during sepsis have
not been investigated.
In the present study, we hypothesized that endothelial HSPA12B regulate
macrophage inflammatory responses. To investigate this hypothesis, we did in
vitro and in vivo experiments to demonstrate that endothelial HSPA12B are
released via exosome secretion during sepsis and that macrophages can uptake
endothelial HSPA12B containing exosomes in both in vivo and in vitro. HSPA12B
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carried by exosomes attenuated macrophage inflammatory response to LPS
stimulation via downregulation of NF-B activation.
Materials and Methods
Animals
Endothelial specific HSPA12B knockout mice (HSPA12B-/-) were
generated by cross-breeding the conditionally targeted HSPA12B mice with
C57BL/6. Cg-Tg (Tek-cre) strain which carries Cre recombinase under the
control of the Tek promoter. HSPA12B-/- mice and age matched wild type (WT)
C57BL/6 mice were used for experiments. The mice were maintained in the
Division of Laboratory Animal Resources at East Tennessee State
University. The experiments outlined in this manuscript conform to the Guide for
the Care and Use of Laboratory Animals published by the National Institutes of
Health (8th edition, 2011). The animal care and experimental protocols were
approved by the Eastern Tennessee State University Committee on Animal Care.
Cecal Ligation Sepsis Model
Murine polymicrobial sepsis was induced by cecal ligation and puncture as
described previously432,440,433,47,75. To induce of a septic model, mice were
anesthetized by 5.0% isoflurane. A midline incision was made on the anterior
abdomen and the cecum was exposed and 1/3 of cecum was ligated with a 4-0
suture. One puncture was made at the end of cecum with a 23-gauge needle and
feces were extruded from the hole. The abdomen was then closed in 2 layers.
Sham surgically operated mice served as sham control. Immediately following
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surgery, a single dose of resuscitative fluid (lactated Ringer’s solution, 50 mL/kg
body weight) was administered by subcutaneous injection.
ELISA for Serum Lactate and Cytokine Assay
The serum levels of serum lactate were measured with commercially
available kits according the instructions provided by the manufacturer (Millipore
Sigma). And Serum inflammatory cytokines (TNF-α, IL-1β and IL-10) were
measured with commercially available kits according the instructions provided by
the manufacturer (Peprotech).
Tissue Accumulation of Macrophages
Accumulation of macrophages in heart tissues were examined using
immunostaining with anti F4/80 antibody (Cell Signaling Technology). Three
slides from each block were evaluated, counterstained with hematoxylin, and
examined with confocal microscopy. The results are expressed as the numbers
of immune cells/field (×40)432,433,47.
Immunofluorescent Staining
The procedure of the immunofluorescent staining was modified based on
the protocol provided by Cell Signaling Technology. Briefly, cells were grown on
the coverslips in a multiwell plate, fixed with 4% formaldehyde for 15 min in room
temperature and washed for three times with PBS for 5 minutes each. Cells were
permeabilized with ice-cold 100% methanol for 10 min at -20oC followed by
rinsing in PBS for 5 min. The cells were incubated with 10% goat serum for 60
min at room temperature followed by incubation with the primary antibody (F4/80,
1:100, Cell signal technology; p65, 1:400, Cell signal technology) that was diluted
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with 10% goat serum, at 4oC overnight according to the instruction provided by
manufacturer. After washing for three times with PBS for 5 min each, the cells
were incubated with a fluorochrome-conjugated secondary antibody for 60 min at
room temperature in dark. The cells were washed with PBS for three times,
covered by antifade reagent with DAPI and examined with confocal microscope.
Flow Cytometric Analysis
The procedure of flow cytometry was modified based on the protocol from
BD Biosciences. Briefly, the cells were harvested from blood and spleen tissues
and prepared for a single cell suspension. Red blood cells were lysed using BD
Pharmingen’s PharM LyseTM(Cat. No.555899) solution. The mixture of cell
suspension was incubated with LyseTM buffer at room temperature for 15 min in
the dark and centrifuged at 200g for 5 minutes at 10oC. The supernatants were
carefully removed. The pellets were suspended with 1x cold wash buffer
(PBS/0.1% NaN3/1.0%FBS) followed by centrifugation at 350g for 5 min. Cells
were counted, and reconstituted in staining buffer (BD Biosciences) to a
concentration of 1x106 cells/ml. Subsequently, cells will be incubated with
LIVE/DEAD Fixable Dead Cell Stain single-color dyes (Invitrogen) for 30 min at
room temperature. After one rinse with washing buffer, cells will be incubated
with anti- Fcᵧ III/II (clone 2.4G2) antibody (BD Pharmingen) for 15 min and
labeled at 4°C overnight followed by incubation with rat anti-mouse primary
antibodies: F4/80-Alexa 647, CD11b-PE-CY7 to label monocytes/macrophages,
and Gr-1-PerCP-Cy5.5, Ly-6B.2-FITC to label neutrophils. Finally, cells will be
washed twice, resuspended in staining buffer and immediately analyzed with a
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Becton Dickinson LSRII ﬂow cytometer (BD Biosciences).
Monocytes/macrophages were identiﬁed using the gating strategy as CD11b+
F4/80+ cells, while neutrophils were identiﬁed using the gating strategy as Gr1+ly6b.2+ cells. Data analysis and quantiﬁcation were performed using FlowJo.
Antibodies dilution will be adjusted for specific experiment according to
manufacture manual.
In vitro Experiments
Human umbilical vein endothelial cells (HUVECs) were cultured in
vascular cell basal medium supplemented with endothelial cell growth kits
(ATCC). After reaching 70%–80% confluence, HUVECs were transfected with
adenovirus expressing HSPA12B (Ad-HSPA12B) or adenovirus expressing GFP.
Six hours after transfection, the cells were washed and incubated with fresh
medium overnight followed by LPS stimulation for four hours. The cells were
harvested, and the cellular proteins were prepared for Western blot118,431.
Transfection of Raw 264.7 Macrophages with Adenovirus Expressing HSPA12B
(Ad-HSPA12B)
The procedure for transfection of macrophages with Ad-HSPA12B was
modified according to K2 transfection system (Biontex). Briefly, when
macrophages reached to 80%–90% confluence, the cells were pre-treated with
K2 multiplier for two hours. K2 transfection reagent and Ad-HSPA12B or Ad-GFP
were mixed at 1:2 ratio and incubated at room temperature for 30 min. The mixed
transfection reagent was added into cultured macrophages. Six hours after
transfection, the cells were washed and incubated with fresh culture medium
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overnight. The transfection efficiency was examined by viewing green
fluorescence in the cells.
Isolation of Exosomes
HUVECs were incubated with FBS-free medium. The medium was
collected and centrifuged at 2000g for 30 min to remove debris. The
supernatants were transferred into a new tube. Thirty percent (30%) PEG6000
(Sigma-Aldrich) reagent was mixed with the supernatant at ratio of 1:2 by
votexing until there is a homogenous solution. The mixture was incubated at
2~8oC overnight and centrifuged at 3000g for 30 min. The supernatant was
removed. Exosomes in the pellet were resuspended in cold PBS and the
exosome markers were examined by Western blot.
Western Blot
Western blot was performed as described previously47,75,432,433. In brief,
cellular proteins were separated by sodium dodecyl sulphate–polyacrylamide gel
electrophoresis and transferred onto Hybond enhanced chemiluminescence
(ECL) membranes (Amersham Pharmacia, Piscataway, New Jersey). The ECL
membranes were incubated with the appropriate primary antibodies followed by
peroxidase-conjugated secondary antibody, which was purchased from Cell
Signaling Technology, Inc. The signals were quantified using the G: Box gel
imaging system by Syngene (Frederick, Maryland).
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Statistical Analysis
The data are expressed as mean ± standard error. Comparisons of data
between groups were made using one-way analysis of variance (ANOVA), and
Tukey procedure for multiple-range tests was performed. The log-rank test was
used to compare group survival trends. Probability levels of ≤.05 were used to
indicate statistical significance.
Results
High levels of serum lactate and inflammatory cytokines in HSPA12B -/- septic
mice
The serum lactate levels serve as a biomarker for severity and mortality of
sepsis.453 Figure 11 shows that CLP sepsis significantly increased the serum
lactate levels in both WT and HSPA12B-/- mice compared with sham controls.
However, the levels of serum lactate in HSPA12B-/- septic mice were markedly
greater by 27.5% than in WT septic mice. Although CLP sepsis also markedly
increased the levels of serum TNF-α, IL-1β and IL-10 in both WT and HSPA12B-/mice 36 hours after induction of CLP sepsis (Figs. 12A-C). Interestingly, the
serum TNF-α and IL-1 β levels in HSPA12B-/- septic mice were markedly
increased by 53.5% and 38.9% while IL-10 decreased by 52.7% at 36 hours after
CLP, when compared with WT septic mice. These data indicate that endothelial
HSPA12B could participate in the regulation of inflammatory cytokine production
during CLP sepsis.
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Figure 11. Endothelial cell specific HSPA12B deficiency exacerbated sepsisinduced production of lactate following polymicrobial sepsis. WT and HSPA12B-/mice were subjected to CLP sepsis. Serum was collected at 36 hours after CLP
sepsis. Serum lactate levels were evaluated by enzyme-linked immunosorbent
assay. HSPA12B deficiency resulted in remarkable increased serum lactate
compared with WT septic mice. (n=3~6/group) *P < 0.05, **P < 0.01, and ***P <
0.001 compared with indicated groups.

Figure 12. Endothelial cell specific HSPA12B deficiency exacerbated sepsisinduced inflammatory cytokine production following polymicrobial sepsis. WT and
HSPA12B-/- mice were subjected to CLP sepsis. Serum was collected at 36
hours after CLP sepsis. The levels of tumor necrosis factor alpha (TNF-α; A),
interleukin 1 beta (IL-1β; B), and interleukin 10 (IL-10; C) were analyzed with
enzyme-linked immunosorbent assay. CLP sepsis significantly alter serum TNF-α,
IL-1β and IL-10 at 36 hours compared with those in the sham groups. However,
HSPA12B deficiency resulted in remarkable increased serum TNF-α and IL-1β
and decreased serum IL-10 compared with WT septic mice. (n=3~6/group) *P
< .05, **P < .01, and ***P < .001 compared with indicated groups.
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Increased accumulation of macrophages in the myocardium of HSPA12B -/- septic
mice
Increased immune cells in the myocardium contributes to septic
cardiomyopathy435,46. Figure 13 shows that the numbers of F4/80+ macrophages
in the myocardium from HSPA12B-/- septic mice were significantly greater than in
WT septic mice. Increased expression of adhesion molecules facilitates immune
cell accumulation in the heart tissues436. The result shown in the chapter 3 has
demonstrated increased levels of ICAM1 and VCAM1 in the myocardium of
HSPA12B-/- septic mice were significantly greater than in WT septic mice. The
data indicates that endothelial cell HSPA12B could attenuate macrophage
infiltration into the myocardium through suppressing myocardial adhesion
molecule expression during sepsis.
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Figure 13. Endothelial cell specific HSPA12B deficiency increased macrophage
population in myocardium following polymicrobial sepsis. Heart was harvested at
36 hours after CLP sepsis for immunofluorescent staining. Heart tissues were
sectioned and stained with anti-F4/80 antibody (green). Nucleus were stained
with DAPI (blue). HSPA12B deficiency increased macrophage (marked by
F4/80+) infiltration into myocardium of septic mice at 36 hours. n=3/group. *P <
0.05, **P < 0.01, and ***P < 0.001 compared with indicated groups.
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Increased monocytes/macrophages population in circulation and spleen in
HSPA12B-/- septic mice
Activation of neutrophils and monocytes/macrophages plays a critical role
in sepsis induced organ injury212,454. We examined the effect of endothelial
HSPA12B on the immune cell populations in circulation and spleen tissue after
induction of CLP sepsis. Figure 14A shows that the numbers of circulation
monocytes were markedly increased in HSPA12B-/- septic mice, but not in WT
septic mice. However, the numbers of circulating and splenic neutrophils in
HSPA12B-/- septic mice were greater than in WT septic mice (Figs. 14B, C). Flow
cytometry analysis shows that there are also more CD11b+/F4/80+ macrophages
populations in the spleen from HSPA12B-/- septic mice, when compared with WT
septic mice (Figs. 15A, B). Further studies on the subsets of CD11b+/F4/80+
macrophages present more proinflammatory macrophages (labeled by
LY6C+/CCR2+) in the spleen of HSPA12B-/- septic mice.(Figure 15C). To
investigate whether septic macrophages contain activated NF-B, we isolated
peritoneal macrophages from WT and HSP12B-/- mice and examined NF-B
subunit p65 nuclear translocation with immunostaining. As shown in Figure 16,
macrophages that were isolated from peritoneal cavity of HSPA12B-/- septic mice
exhibit greater NF-B p65 subunit nuclear translocation than in WT septic mice.
These data indicate that endothelial HSPA12B could regulate macrophage
response to CLP sepsis challenge and regulate macrophage inflammatory
response.
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Figure 14. Increased macrophage populations in circulation and altered
neutrophils populations in circulation and spleen in HSPA12B-/- septic mice. WT
and HSPA12B-/- mice were subjected to CLP sepsis. Blood, and spleen were
harvested at 36 hours after CLP for analysis of macrophage and neutrophil
populations. (A) Flow cytometry analysis of the monocytes in blood with antiCD11b+antibodies, and the neutrophils (Gr-1+ly6b.2+) in blood (B) and spleen (C)
with anti-Gr-1+Ly6b.2+ antibodies. n=3~5/group *P < 0.05, **P < 0.01, and ***P <
0.001 compared with indicated groups.

Figure 15. Increased pro-inflammatory macrophage populations in spleen in
HSPA12B-/- septic mice. A) Gating strategy in Flow cytometry analysis of the
macrophage population in spleen. Macrophages in spleen were identified based
on the combination with anti-CD11b+F4/80+ antibodies (B) and pro-inflammatory
macrophages were identified based on combination with anti-Ly6C+/CCR2+
antibodies (C) from CD11b+F4/80+ macrophages. n=3~5/group. *P < 0.05, **P <
0.01, and ***P < 0.001 compared with indicated groups.
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Figure 16. Activation of macrophages from peritoneal cavity in HSPA12B-/- septic
mice. WT and HSPA12B-/- mice were subjected to CLP sepsis. Peritoneal
macrophages were collected at 36 hours after CLP sepsis, which were plated for
2 hours, then adherent cells (macrophages) were stained for P65 (red), F4/80
(green) and DAPI (blue) to indicate activation of peritoneal macrophages.

Tissue Exosomes Contain Endothelial HSPA12B in WT Mice
Exosomes have been demonstrated to play a critical role in mediated cellcell and tissue-tissue communication454,236. We examined whether endothelial
HSPA12B could be released via exosome secretion. Exosomes were isolated
from tissues for examination of HSPA12B by Western blot. Figure 17 shows that
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the exosomes isolated from the heart, lung, kidney and spleen tissues from WT,
but not HSPA12B-/- septic mice contain HSPA12B. Since HSPA12B is mainly
expressed in endothelial cells111, the data indicates HSPA12B could be released
from endothelial cells via exosome secretion.

Figure 17. Tissue exosomes contain endothelial HSPA12B in WT mice. (A-C)
exosomes were isolated from heart (A), Spleen (B), and Kidney (C) of WT and
HSPA12B-/- mice.

Endothelial HSPA12B can Be Uptaken by Macrophages
To define whether HSPA12B containing exosomes can be up taken by
macrophages, we transfected endothelial cells (HUVECs) with adenovirus
expressing HSPA12B (Ad-HSPA12B) or Ad-GFP served as vector control.
Twenty-four hours after transfection, we harvested the medium as an endothelial
conditioned medium (ECM), incubated the macrophages (Raw 246.7) with the
ECM, and examined whether endothelial HSPA12B could be up taken by
macrophages. As shown in Figure 18, green fluorescence that indicates
endothelial HSPA12B appeared in the macrophages that were incubated with
ECM from the HUVECs transfected with Ad-HSPA12B (containing green
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fluorescence), but not from Ad-GFP transfected HUVECs. Interestingly,
stimulation of HUVECs with LPS increased HSPA12B in the ECM as evidenced
showing that macrophages contained more fluorescence than control group. The
data indicates that LPS stimulation could promote endothelial cells to release
HSPA12B via exosome secretion. To confirm our finding, we transfected
HUVECs with Ad-HSPA12B or Ad-GFP for 24 hours, isolated exosomes from
cultured medium, and incubated macrophages with the isolated exosomes.
Figure 19 shows that endothelial HSPA12B containing exosomes were up taken
by macrophages. The data demonstrated that endothelial cell HSPA12B could be
transmitted into macrophages via uptake of exosomes.

Figure 18.Macrophages uptake endothelial exosomes that contain HSPA12B.
Macrophages uptake endothelial HSPA12B from endothelial cell conditioned
medium. HUVECs were transfected with Ad-HSPA12B or Ad-GFP. Twenty-four
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hours after transfection, the cultured medium was collected as the endothelial
conditioned medium (ECM). Macrophages (Raw 264.7) were incubated with
ECM. Endothelial HSPA12B in macrophages were examined with fluorescent
microscope. HSPA12B exhibits green. Macrophages were strained with antiF4/80 antibody. Nucleus was stained with DAPI.

Figure 19. Macrophages uptake endothelial exosomes that contain high levels of
HSPA12B. A) The levels of HSPA12B in Exosomes from ECM were evaluated by
western blot. CD9 serves as a loading control for exosomes. B) Macrophages
were incubated with endothelial exosomes that were isolated from ECM for one
hour. Endothelial HSPA12B (green) in macrophages was viewed with fluorescent
microscope.

Endothelial Conditioned Medium (ECM) Attenuated LPS Stimulated Inflammatory
Cytokine Production in Macrophages
To investigate that HSPA12B released from endothelial cells could
regulate the inflammatory cytokine production in macrophages, we first incubated
macrophages with ECM before the cells were stimulated with LPS. Figures 20AC show that LPS stimulation markedly increased the levels of TNF (A), IL-1β (B)
and IL-10 (C) compared with unstimulated control. However, ECM harvested
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from Ad-HSPA12B transfected HUVECs, but not from Ad-GFP transfected
HUVECs significantly attenuated LPS stimulated production of TNF by 20.4%
and IL-1β by 60.6% in macrophages. Interestingly, ECM harvested from AdHSPA12B transfected endothelial cells further enhanced LPS stimulated IL-10
production (by 27.3%) in macrophages. Similarly, incubation of bone marrow
derived macrophages (BMDMs) with ECM collected from Ad-HSPA12B
transfected HUVECs markedly suppressed LPS stimulated TNF and IL-1β
production and enhanced IL-10 production (Figs. 21A-C). The data suggests that
endothelial HSPA12B could regulate macrophage response to LPS stimulation.

Figure 20. Endothelial conditioned medium (ECM) altered macrophage response
to LPS stimulation. Raw 264.7 macrophages were incubated with ECM followed
by LPS (1 µg/ml) stimulation for 24 hours. The medium was collected for the
measurement of TNFα (A), IL-1β (B) and IL-10 (C) by ELISA. *P < 0.05, **P <
0.01, and ***P < 0.001 compared with indicated groups. C, En-C, En-G and En12B indicate Control, endothelial-control, endothelial-Ad-GFP, and endothelialAd-HSPA12B separately.
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Figure 21. Endothelial conditioned medium (ECM) altered macrophage response
to LPS stimulation. (A-C) Bone marrow derived macrophages (BMDM) were
incubated with ECM followed by LPS (1 µg/ml) stimulation for 24 hours. The
medium was collected for the measurement of TNF-α (A), IL-1β (B) and IL-10 (C)
by ELISA. n= 3~4/group.

Endothelial HSPA12B Containing Exosomes Regulate Inflammatory Responses
in Macrophages
We have shown that HSPA12B can be released from endothelial cells via
exosomes (Fig. 19). We then investigated whether HSPA12B released by
endothelial cells could regulate macrophage response to LPS stimulation.
Endothelial exosomes were isolated from ECM that was collected from cultured
endothelial cells (HUVECs) transfected with or without Ad-HSPA12B or Ad-GFP
(defined as exosomes/control, exosomes/GFP and exosomes/HSPA12B).
Macrophages were incubated with the isolated endothelial exosomes followed by
LPS stimulation. Figures 22A-C show that LPS stimulation markedly increased
TNF (A), IL-1β (B) and IL-10 (C) production in macrophages. Importantly,
exosomes/HSPA12B, but not exosomes/GFP or exosomes/control significantly
attenuated LPS induced increases in TNF and IL-1β levels and enhanced LPS

107

stimulated IL-10 production in macrophages. The data suggests that exosomes
with high levels of HSPA12B could attenuate the response of macrophages to
LPS challenge.
To confirm the role of HSPA12B in exosomes/HSPA12B regulating
macrophage response to LPS stimulation, we directly transfected macrophages
with Ad-HSPA12B or Ad-GFP 24 hours before the cells were stimulated with LPS.
Figure 23A shows that high levels of HSPA12B were observed in the
macrophages that were directly transfected with Ad-HSPA12B. Figures 23B-D
show that transfection of Ad-HSPA12B, but not Ad-GFP attenuated LPS
stimulated TNF and IL-1β production and enhanced LPS stimulated IL-10 in
macrophages. The data demonstrated that endothelial HSPA12B can regulate
the response of macrophages to LPS stimulation.

Figure 22. Endothelial exosomes altered macrophage response to LPS
stimulation. Exosomes were isolated from HUVECs that were transfected with
Ad-HSPA12B or Ad-GFP followed by LPS stimulation for 24 hours. Macrophages
(RAW 264.7) were incubated with the isolated exosomes before LPS (1 µg/ml)
stimulation for 24 hours. The medium was collected for measurement of TNF-α
(A), IL-1β (B) and IL-10 (C) with ELISA. n= 4/group.
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Figure 23. HSPA12B directly alters macrophage response to LPS stimulation. (A)
Western blot analysis of HSPA12B levels in macrophages. The cultured medium
was collected for the measurement of TNF-α (B), IL-1β (C) and increased IL-10
(D) with ELISA. N= 3~4/group. *P <0.05, **P <0.01, and ***P <0.001 compared
with indicated groups.

Endothelial HSPA12B Containing Exosomes Downregulate NF-B Activation in
LPS Stimulated Macrophages
To investigate the mechanisms by which endothelial HSPA12B regulates
macrophage response to LPS stimulation, we examined NF-B activation in
macrophages. Confocal microscopy examination shows that LPS stimulation
induced NF-B subunit p65 nuclear translocation (Fig. 24A). Western blot
analysis shows that LPS stimulation increased the levels of phosphorylated IB
(Fig. 24B) in macrophages. However, exosomes/HSPA12B administration
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markedly attenuated LPS induced NF-B subunit p65 nuclear translocation (A),
IB phosphorylation (B). In addition, directly transfection of macrophages with
ad-HSPA12B, but not ad-GFP significantly attenuated LPS induced IB
phosphorylation (Fig.25A) and NF-B subunit p65 nuclear translocation (Fig.25B).
These data suggest that endothelial HSPA12B can directly regulate macrophage
response to LPS stimulation via downregulation of NF-B activation.
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Figure 24. Endothelial exosomes that contain high levels of HSPA12B altered
NF-κB activation in LPS stimulated macrophages. Exosomes were isolated from
HEVECs that were transfected with Ad-HSPA12B or Ad-GFP followed by LPS
stimulation for 24 hours. Macrophages (RAW 264.7) were incubated with the
isolated exosomes for two hours prior to LPS (1 µg/ml) stimulation for one hour.
(A) Immunostaining of NF-B subunit p65 (red) nuclear translocation. The
nucleus was stained with DAPI (blue). (B) Macrophages (RAW 264.7) were
incubated with the endothelial exosomes (5 µg/ml) for 8 hours followed by LPS
stimulation for one hour. Phosphorylated IBα and total IBα were assessed with
Western blot. N=3~4/group. *P < 0.05, and ***P < 0.001 compared with
indicated groups.

Figure 25. HSPA12B directly alters NF-κB activation in LPS stimulated
macrophages. Macrophages (RAW 264.7) were transfected with the Ad111

HSPA12B-GFP or Ad-GFP for 6 hours by K2 transfection reagents separately for
8 hours, then cultured with fresh medium followed by LPS stimulation for half
hour. Phosphorylated IBα (A) and total IBα (A) in the cytoplasm and the levels
of nuclear NF-B subunit p65 (B), were assessed with Western blot.
N=3~4/group. *P < 0.05, and ***P < 0.001 compared with indicated groups.
Discussion
The present study demonstrated that endothelial HSPA12B exerts a
protective role in sepsis by limiting cardiac dysfunction and maintaining survival,
shown in the chapter 2. We also found that endothelial HSPA12B is released via
exosome secretion. Recent evidence has shown that exosomes play a critical
role in mediating cells-to-cell and organ-to-organ communication236,455.
Interestingly, we found that the endothelial exosomes containing HSPA12B can
be uptaken by macrophages, where it downregulates macrophage proinflammatory cytokine production and enhances IL-10 levels in response to LPS.
Our data provides compelling evidence that there is crosstalk between
endothelial cells and macrophages during sepsis and that endothelial cells can
regulate macrophage function through exosomal HSPA12B.
Endothelial HSPA12B has been reported to attenuate endotoxemia 113 and
cardiac injury due to myocardial infarction115. The mechanisms involve activation
of PI3K/Akt signaling and suppression of NF-B activation113,115. Endothelial
HSPA12B also protects vascular endothelial cells from sepsis induced acute lung
injury437. We observed in the present study that deficiency of HSPA12B in
endothelial cells results in severe cardiac dysfunction, decreased survival
outcome, and increased pro-inflammatory cytokine production in polymicrobial
sepsis. These findings provide further evidence that endothelial cell HSPA12B
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plays an important role in limiting pro-inflammatory responses and protecting the
host against sepsis induced cardiomyopathy and mortality.
To elucidate the mechanisms by which endothelial HSPA12B attenuates
sepsis induced cardiomyopathy and organ injury, we focused on the role of
endothelial HSPA12B in the regulation of macrophage inflammatory response to
sepsis. Recent evidence highlighted the role of macrophage function in sepsis
induce organ dysfunction46,47. We found that endothelial HSPA12B deficiency
results in higher levels of adhesion molecules in the myocardium, which are
associated with increased macrophage infiltration into the heart during CLP
sepsis. Our observation suggests that endothelial HSPA12B not only regulates
the expression of adhesion molecules on endothelial cells, but it also regulates
macrophage inflammatory response during sepsis. It is well known that
endothelial cell dysfunction contributes to sepsis induced multiple organ
dysfunction456. Increased expression of HSPA12B prevents LPS-induced
increases in the expression of adhesion molecules (ICAM1 and VCAM1) and
attenuates LPS-induced inflammatory responses in endothelial cells113,118. We
have previously demonstrated that endothelial HSPA12B downregulates
adhesion molecule expression via microRNA-126 (unpublished data). In the
present study, we demonstrated that endothelial cells can release HSPA12B in
exosomes and that exosomal HSPA12B can be uptaken by macrophages. This
observation indicates that endothelial HSPA12B mediate crosstalk between
endothelial cells and macrophages in the response to septic challenge. Of
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greater importance, endothelial HSPA12B exerts an anti-inflammatory effect on
macrophages.
Previous studies have shown that there is crosstalk between endothelial
cells and macrophages during sepsis and/or inflammatory diseases303,457.
Increasing evidence suggests that endothelial cells and macrophages engage via
specific interactions to regulate vascular function458,459. Adult endothelial cells
provide critical signals for the selective growth and differentiation of
macrophages from several hematopoietic progenitors460,461. Thus, endothelial
cells may serve as endogenous regulators for the activation or suppression of
macrophage mediated innate immune and inflammatory responses. Indeed, we
observed that the endothelial cell conditioned medium (ECM) generated from AdHSPA12B transfected endothelial cells markedly downregulated LPS stimulated
inflammatory cytokine production by macrophages, suggesting that endothelial
HSPA12B could regulate macrophage response to LPS stimulation.
Exosomes have been demonstrated to play a critical role in the cellular
communication in both physiological and pathological conditions455,236. Exosomes
carry on components, including proteins, lipids, mRNA, and miRNAs from parent
cells, which could be taken up by and affect the functions of recipient cells 462.
Njock et al reported endothelial vehicles (EVs) loaded with miRNAs suppress
inflammatory response in monocytes/macrophages303. He et al reported the
endothelial EVs modulated macrophage polarization toward M2 antiinflammatory phenotype304. Interestingly, we observed that exosomes isolated
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from tissues contain HSPA12B. In vitro data shows that HSPA12B can be
transmitted from endothelial cells to macrophages via exosomes.
We also found that endothelial HSPA12B is uptaken by macrophages and
that it markedly downregulated LPS stimulated pro-inflammatory cytokine
production and enhanced IL-10 levels. To confirm our observation, we performed
direct transfection of macrophages with Ad-HSPA12B and observed that
transfected HSPA12B suppressed LPS increased the levels of pro-inflammatory
cytokines and enhanced anti-inflammatory cytokine production. The data strongly
supports the concept that endothelial HSPA12B can regulate macrophage
response to LPS stimulation.
Activation of NF-κB pathway contributes to sepsis induced mortality and
organ dysfunction463. Our previous studies have demonstrated that targeting Tolllike receptors (TLRs) mediated NF-κB activation pathway increased survival
outcome in ploymicriobial sepsis440,47. The present study demonstrated that
endothelial HSPA12B significantly suppresses IB phosphorylation and NF-B
subunit P65 nuclear translocation in LPS stimulated macrophages, suggesting
that endothelial HSPA12B regulates NF-B activation in macrophages. Future
studies are needed to investigate the mechanisms by which endothelial
HSPA12B suppresses NF-B activation in LPS challenged macrophages.
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CHAPTER 4. β-GLUCAN DOWNREGULATES INFLAMMATORY RESPONSES
IN PLOYMICROBIAL SEPSIS BY A CROSSTALK BETWEEN MACROPHAGES
AND ENDOTHELIAL CELLS THROUGH EXOSOMAL HSPA12B

Introduction
Traditionally, immune systems in vertebrate animals consist of innate
immunity and adaptive immunity.464 It is immunological memory that
distinguishes adaptive immunity from innate immunity. Innate immune cells lack
the immune memory to respond quickly to secondary stimulations.465 However, a
series of exciting studies led by Netea and colleagues have challenged this
conventional notion. It was Netea who coined the term “trained immunity”, when
he discovered that myeloid cells hold immune memory to respond to secondary
stimulation quickly and non-specifically.333,356,357,410,352
β-1,3-(D)-glucan (β-glucan), a major component of the Candida cell wall,
has been recognized as an immune-stimulator, to modulate innate immunity,
and the proinflammatory signaling pathway.75 It does this by binding with receptor,
Dectin-1, expressed on the membrane of immune cells, to activate them.466,467
The previous studies by our lab have reported that β-glucan administration
before induction of sepsis protects against sepsis-induced mortality, by
downregulating the NF-κB signaling pathway to suppress proinflammatory
responses in a murine of CLP sepsis.468,440 In previous experiments in septic
mice , β-glucan was administered by intraperitoneal injection 1 hour before
surgery. Therefore, the protection of β-glucan is not associated with immune
memory in innate immune cells, due to the short gap between β-glucan
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administration and surgery .440,468,469 Recent studies have shown that β-glucan
administration 7 days before S. aureus infection significantly increased the
survival rate from 40% to 90% in S. aureus induced sepsis. Increased survival
outcome is mediated by hypoxia-induced factor 1α (HIF-1α) regulating aerobic
glycolysis in myeloid cells357. The data indicates the critical role of β-glucaninduced trained immunity against bacterial stimulation. However, the mechanism
by which β-glucan-induced trained immunity in CLP sepsis is still unclear.
Endothelium, formed by endothelial cells, has been reported to regulate
macrophage inflammatory responses during sepsis.49 In the previous chapter, we
have demonstrated that endothelial HSPA12B, released via exosomes, could be
captured by macrophages and subsequently decrease inflammatory responses.
Meanwhile, barely derived β-glucan plays a role in the regulation of endothelial
cell functions.414,415. Moreover, β-glucan trained monocytes/macrophages exhibit
sensitive and strong responses to secondary stimulations in vitro.339 However,
the contribution of β-glucan for the interaction between macrophages and
endothelial cells remain unknown.
In our current study, we hypothesized that β-glucan induced trained
immunity benefits the survival outcome of septic mice through a crosstalk
between endothelial cells and macrophages. To test this hypothesis, we did in
vitro and in vivo experiments that demonstrate β-glucan can induce trained
endothelial cells that regulate innate immunity to improve survival outcome of
CLP sepsis. The mechanisms involve increased endothelial cell HSPA12B
expression and release via exosome secretion. The endothelial exosomal
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HSPA12B downregulates activated NF-B mediated inflammatory response in
macrophages.
Materials and methods
Animals
Endothelial specific HSPA12B knockout mice (HSPA12B-/-) were
generated by cross-breeding the conditionally targeted HSPA12B mice with
C57BL/6. Cg-Tg (Tek-cre) strain which carries Cre recombinase under the
control of the Tek promoter. HSPA12B-/- mice and age matched wild type (WT)
C57BL/6 mice were used for experiments. The mice were maintained in the
Division of Laboratory Animal Resources at East Tennessee State
University. The experiments outlined in this manuscript conform to the Guide for
the Care and Use of Laboratory Animals published by the National Institutes of
Health (8th edition, 2011). The animal care and experimental protocols were
approved by the Eastern Tennessee State University Committee on Animal Care.
Cecal Ligation Sepsis Model
Murine polymicrobial sepsis was induced by cecal ligation and puncture as
described previously432,440,433,47,75. To induce of a septic model, mice were
anesthetized by 5.0% isoflurane. A midline incision was made on the anterior
abdomen and the cecum was exposed and 1/3 of cecum was ligated with a 4-0
suture. One puncture was made at the end of cecum with a 23-gauge needle and
feces were extruded from the hole. The abdomen was then closed in 2 layers.
Sham surgically operated mice served as sham control. Immediately following
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surgery, a single dose of resuscitative fluid (lactated Ringer’s solution, 50 mL/kg
body weight) was administered by subcutaneous injection.
Immunofluorescent Staining
The procedure of the immunofluorescent staining was modified based on
the protocol provided by Cell Signaling Technology. Briefly, cells were grown on
the coverslips in a multiwell plate, fixed with 4% formaldehyde for 15 min in room
temperature and washed for three times with PBS for 5 minutes each. Cells were
permeabilized with ice-cold 100% methanol for 10 min at -20oC followed by
rinsing in PBS for 5 min. The cells were incubated with 10% goat serum for 60
min at room temperature followed by incubation with the primary antibody (p65,
1:400, Cell signal technology) that was diluted with 10% goat serum, at 4oC
overnight according to the instruction provided by manufacturer. After washing
for three times with PBS for 5 min each, the cells were incubated with a
fluorochrome-conjugated secondary antibody for 60 min at room temperature in
dark. The cells were washed with PBS for three times, covered by antifade
reagent with DAPI and examined with confocal microscope.
Isolation of Exosomes
HUVECs were incubated with FBS-free medium. The medium was
collected and centrifuged at 2000g for 30 min to remove debris. The
supernatants were transferred into a new tube. 30% PEG6000 (Sigma-Aldrich)
reagent was mixed with the supernatant at ratio of 1:2 by votexing until there is a
homogenous solution. The mixture was incubated at 2~8oC overnight and
centrifuged at 3000g for 30 min. The supernatant was removed. Exosomes in the
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pellet were resuspended in cold PBS and the exosome markers were examined
by Western blot.
Western Blot
Western blot was performed as described previously47,75,432,433. In brief,
cellular proteins were separated by sodium dodecyl sulphate–polyacrylamide gel
electrophoresis and transferred onto Hybond enhanced chemiluminescence
(ECL) membranes (Amersham Pharmacia, Piscataway, New Jersey). The ECL
membranes were incubated with the appropriate primary antibodies followed by
peroxidase-conjugated secondary antibody, which was purchased from Cell
Signaling Technology, Inc. The signals were quantified using the G: Box gel
imaging system by Syngene (Frederick, Maryland).
ELISA for Cytokine Assay
The serum levels of aspartate aminotransferase (AST, hepatic injury
marker) and creatinine (kidney injury marker) were measured with commercially
available kits according the instructions provided by the manufacturer (Millipore
Sigma). And serum inflammatory cytokines (TNF-α, IL-1β and IL-6) were
measured with commercially available kits according the instructions provided by
the manufacturer (Peprotech).
Flow Cytometric Analysis
Seed HUVECs at a density of 2.0x105 cells in 6-well plate until the cells
are ~90% confluent. Abandon the medium followed with 1ml warm PBS wash
and 0.5ml warm PBS incubate cells at incubator for 5min~10min. Pellet the cells
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at 350g for 10 min and suspended with 50ul blocking buffer (0.5% NRS, 0.5%
BSA, 5mM EDTA, 0.1% NaN3) for 106 cells, and incubate on ice for 5 min.
Antibody incubation (Dectin-1,10ul) at 0.5~1h on ice in the dark. Pellet the cells
at 350g for 5 min and suspend with 100ul wash buffer (PBS/0.1% NaN3/1% FBS).
Transfer the 100ul cell mixture into tubes with 250ul wash buffer prior to test by
flow cytometry.
Statistical Analysis
The data are expressed as mean ± standard error. Comparisons of data
between groups were made using one-way analysis of variance (ANOVA), and
Tukey procedure for multiple-range tests was performed. The log-rank test was
used to compare group survival trends. Probability levels of ≤.05 were used to
indicate statistical significance.
Results
β-Glucan Increased Survival Outcome and Attenuated Immune and Inflammatory
Responses in Polymicrobial Sepsis
To investigate whether β-glucan could improve survival outcome of sepsis,
WT mice were trained with 1 mg β-glucan intraperitoneally (i.p.) 7 days prior to
CLP sepsis. As shown in Figure 26, β-glucan trained septic mice exhibited an
increased survival outcome by 18% compared with septic mice. The time to
reach a 62% mortality of WT septic mice was ~110 hours, while a mortality of 44%
of β-glucan trained septic mice was 200 hours, after induction of CLP sepsis.
However, the increased survival outcome wasn’t statistically significant, which
may be due to the limited number of β-glucan trained septic mice.
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Moreover, although CLP sepsis significantly increased serum TNF-α and
IL-6 levels at 36 hours, β-glucan markedly attenuated the levels of serum TNF-α
(Fig.27A) and IL-6(Fig.27B) by 22.99% and 51.91% separately, compared with
the counterparts in septic mice. The data suggests that β-glucan, a reagent for
trained immunity could improve survival outcome of CLP sepsis with attenuated
immune responses.
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Figure 26. β-glucan, a reagent for trained immunity is involved in the regulation of
mortality in polymicrobial sepsis. 1mg fresh β-glucan solution was injected into
WT mice by i.p. 7 days prior to CLP sepsis. The survival outcome was monitored
for last to 200 hours following induction of CLP. n=9~21/group.
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Figure 27. β-glucan, a reagent for trained immunity is involved in the regulation of
immune responses in polymicrobial sepsis. 1mg fresh β-glucan solution was
injected into WT mice by i.p. 7 days prior to CLP sepsis. Serum was collected at
36 hours after CLP sepsis. The levels of TNF-α and IL-6 was analyzed with
enzyme-linked immunosorbent assay. CLP sepsis significantly altered serum
TNF-α (A) and IL-6(B) levels at 36 hours septic mice. However, β-glucan
markedly attenuated the levels of serum TNF-α and IL-6, compared with the
counterparts in septic mice. n= 4~6/group. *P < .05, **P < .01, and ***P < .001
compared with indicated groups.

β-Glucan Increases the Levels of HSPA12B in Endothelial Cells and the
Exosomes Derived from Endothelial Cells in vitro
Due to the protective role of HSPA12B in sepsis, shown in the previous
chapters, we tested the role of β-glucan in the regulation of HSPA12B expression
in endothelial cells. β-glucan was incubated with HUVECs for 24 hours. As
shown in Figure 27A, β-glucan can markedly enhance the expression of
HSPA12B in endothelial cells, which indicates the role of β-glucan in the
regulation of endothelial cell function. Furthermore, β-glucan remarkably
augmented the levels of HSPA12B in exosomes secreted from endothelial cells.
Moreover, β-glucan treatment induced increased expression of Dectin-1 on
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endothelial cells. The data suggests the regulation of β-glucan in HSPA12B
expression may be through Dectin-1 in endothelial cells.

Figure 28. β-glucan regulates levels of HSPA12B in endothelial cells and
endothelial cell derived exosomes. (1ug/ml) fresh β-glucan in endothelial medium
was incubated with endothelial cells for 24 hours. The levels of HSPA12B in
endothelial cells (A) and endothelial exosomes (B) were evaluated by western
blot. n=4/group. (C) (1ug/ml) fresh β-glucan in endothelial medium was incubated
with endothelial cells for 5 hours. Cells were harvested to detect expression of
dectin-1 by flow cytometry. *P < 0.05, **P < 0.01, and ***P < 0.001 compared
with indicated groups.
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Exosomes from β-glucan Treated Endothelial Cells Downregulate Inflammatory
Responses in LPS-Stimulated Macrophages
Due to the suppression of HSPA12B in inflammatory responses in LPSstimulated macrophages, we further investigated the roles of exosomes from βglucan treated endothelial cells (Glucan-exosomes). Figure29A-B show that LPS
stimulation markedly increased the levels of TNF (A), and IL-6(B) compared
with unstimulated control. However, Glucan-exosomes significantly attenuated
LPS stimulated production of TNF by 13.44%, and IL-6 by 25.77% in
macrophages. The data indicates that β-glucan significantly increased levels of
HSPA12B in endothelial exosomes which may contribute to the attenuation of
macrophage inflammatory response to LPS challenge.

Figure 29. Exosomes from β-glucan treated endothelial cells downregulate
inflammatory responses in LPS-stimulated macrophages. Exosomes were
collected from (1ug/ml) treated endothelial cells and were used to incubate with
macrophages for 2 hours followed by LPS (1ug/ml) stimulation for 24 hours. The
medium was collected for the measurement of TNF-α (A), and IL-6 (B) by ELISA.
n= 4~5/group. *P < .05, **P < .01, and ***P < .001 compared with indicated
groups.
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Exosomes from β-Glucan Treated Endothelial Cells Suppress the Translocation
of Nuclear NF-B Subunit p65 in LPS-Stimulated Macrophages
To investigate the mechanisms by which Glucan-exosomes regulate
macrophage response to LPS stimulation, we examined NF-B activation in
macrophages. Confocal microscopy examination shows that LPS stimulation
induces NF-B subunit p65 nuclear translocation. As shown in figure 29, Glucanexosomes incubating with macrophages markedly attenuated LPS induced NFB subunit p65 nuclear translocation. This data suggests that glucan-exosomes
could directly regulate macrophage responses to LPS stimulation via the
downregulation of NF-B activation.
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Figure 30. Exosomes from β-glucan treated endothelial cells downregulate
inflammatory responses in LPS-stimulated macrophages. Exosomes were
collected from the medium of β-glucan (1ug/ml) treated endothelial cells and
were used to incubate with macrophages for 2 hours followed by LPS(1ug/ml)
stimulation for one hour.) Immunostaining of NF-B subunit p65 (red) nuclear
translocation. The nucleus was stained with DAPI (blue).

β-Glucan Induced Trained Immunity Partially Rescues HSPA12B Deficiency
Induced Mortality in Polymicrobial Sepsis
To investigate whether β-glucan induced trained immunity could reduce
the severe mortality induced by HSPA12B deficiency, we examine the effect of βglucan induced trained immunity on the survival outcome in CLP septic mice.
HSPA12B-/- mice were trained with 1 mg β-glucan i.p. 7 days prior to CLP sepsis.
As shown in Figure 30, compared with 100% mortality in HSPA12B-/- septic mice,
β-glucan trained HSPA12B-/- septic mice exhibited an increased survival outcome
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by 17% until the end of the observation. The data suggests that β-glucan induced
trained immunity plays an important role in the protection against mortality in
sepsis.

Figure 31. β-glucan-induced trained immunity partially rescues HSPA12B
deficiency induced mortality in polymicrobial sepsis.1mg fresh β-glucan solution
was injected into WT and HSPA12B-/- mice by i.p. 7 days prior to CLP sepsis.
The survival outcome was monitored for last to 200 hours following induction of
CLP (n=9~27/group). group *P < .05, **P < .01, and ***P < .001 compared with
indicated groups.

β-Glucan Induced Trained Immunity Rescues HSPA12B-/- Induced Increased
Inflammatory Cytokine in Polymicrobial Sepsis
Due to the non-specific protective immunological memory, induced by βglucan induced trained immunity, we further tested whether β-glucan induced
trained immunity regulates immune responses in CLP sepsis. Figure32 shows
that although sepsis markedly increases serum TNF-α levels in both septic
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groups, higher levels of serum TNF-α, caused by HSPA12B deficiency, was
attenuated by β-glucan induced trained immunity. This is remarkably close to the
counterpart in the serum of WT septic mice. The data suggests that β-glucan
induced trained immunity may play a protective role against the upregulation of
immune responses caused by HSPA12B deficiency in CLP sepsis.

Figure 32. β-glucan-induced trained immunity attenuates HSPA12B deficiency
induced increased inflammatory cytokine in polymicrobial sepsis. Serum was
collected at 36 hours after CLP sepsis. The levels of TNF-α was analyzed with
enzyme-linked immunosorbent assay. CLP sepsis significantly altered serum
TNF-α at 36 hours between WT septic mice and HSPA12B-/- septic mice.
However, HSPA12B deficiency resulted in remarkable increased serum TNF-α
compared with WT septic mice, which was attenuated by β-glucan. n=4~5/group
*P < .05, **P < .01, and ***P < .001 compared with indicated groups.
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Discussion
The present study demonstrates that β-glucan induced trained immunity
plays a protective role in CLP sepsis-induced mortality. The mechanisms of βglucan induced trained immunity may involve the regulation of endothelial cell
function to modulate macrophage inflammatory responses. Our data suggests
that there is crosstalk between endothelial cells and macrophages during sepsis,
and that endothelial cells can regulate macrophage pro-inflammatory function
through endothelial exosomal HSPA12B with β-glucan stimulation.
Trained immunity has been reported to modulate innate immune cells to
acquire immune memory, which protects the host with quick and broad
responses to re-infection and benefits survival outcome in animal
pathophysiological settings and vaccinated humans470. β-glucan, as a major
component of fungal cell walls, is used to trained monocytes/macrophages to
obtain immune memory against non-specific secondary infection. β-glucan can
alter epigenetics in innate cells and these alterations can even last from weeks
to months.339,355 In the present study, we found β-glucan trained mice display
much less mortality with decreased pro-inflammatory cytokine production in CLP
sepsis. This indicates the protective role of β-glucan-induced trained immunity in
limiting pro-inflammatory responses and protecting the host against CLP sepsis
induced mortality. Further studies are required to investigate the mechanism by
which reduced pro-inflammatory responses caused by β-glucan-induced trained
immunity is related with the epigenetic modification in the macrophages.
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To elucidate the mechanisms by which β-glucan induced trained immunity
attenuates sepsis-induced inflammatory responses, we focused on the role of βglucan in the regulation of functions of endothelial cells, and its contribution to the
regulation of macrophage inflammatory response to CLP sepsis. Recent studies
reported that barley β-glucan can contribute to angiogenesis .414,415 Interestingly,
our present study indicated that β-glucan promotes the levels of HSPA12B in
endothelial cells, and even in endothelial exosomes. Dectin-1, as a receptor of βglucan, is mainly expressed on the immune cells.467,466 Current study has
demonstrated the presence of Dectin1 in non-immune cells471, like endothelial
cells, and our research discovered the increased levels of Dectin-1 in endothelial
cells treated by β-glucan. The data indicates the increased expression of
HSPA12B in endothelial cells may by via the Dectin1-related signal pathway, but
further studies are needed to confirm Which Dectin-1 related signal pathway is
involved in the regulation of increased endothelial HSPA12B exrepssion.
Additionally, our study found that an increase of HSPA12B in endothelial
exosomes, by β-glucan treatment, can markedly attenuate pro-inflammatory
cytokine production in LPS-stimulated macrophages. This decreased proinflammatory cytokine production is a result of the suppression of NF-κB subset
p65 nuclear translocation by endothelial exosomal HSPA12B in macrophages.
To elucidate whether β-glucan induced trained immunity decreases the worse
survival outcome caused by HSPA12B deficiency during CLP sepsis, HSPA12B-/mice were administrated with β-glucan 7 days before CLP sepsis for survival
monitering. Interestingly, β-glucan-induced trained immunity significantly
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enhanced survival outcome by 17% in β-glucan trained HSPA12B-/- septic mice,
compared with untrained HSPA12B-/- septic mice. Moreover, β-glucan treatment
significantly reduces the increased level of TNF-α induced by HSPA12B
deficiency. This data suggests that β-glucan-induced trained immunity can partly
rescue HSAP12B deficiency induced mortality in CLP sepsis, which More work
is needed to figure out how β-glucan produces an increase of HSPA12B
expression in endothelial cells and whether decreased macrophage inflammatory
responses, induced by endothelial HSPA12B, is associated with epigenetic
change.
To the best of our knowledge, this is the first report that an increase of
endothelial HSPA12B can be released through exosome secretion by β-glucan
treatment. Moreover, the endothelial exosomal HSPA12B mediates crosstalk
between endothelial cells and macrophages during CLP sepsis. This crosstalk is
a result of endothelial exosomal HSPA12B, regulating macrophage proinflammatory cytokine production, via the attenuation of NF-B activation.

132

CHAPTER 5. CONCLUSIONS

Although there have been advances in the clinical management and
scientific understanding of sepsis, it is still one of the leading contributors of
death in hospitals, costs the United States around 20 billion annually, and is
currently incurable. Sepsis is regarded as a pathophysiological condition,
induced by dysregulated immune responses, which in turn cause multiple organ
failure, a great contributor to mortality in the clinic. Cardiovascular dysfunction is
a common complication of sepsis and severe sepsis and leads to a higher
likelihood of death. Sadly, there are no drugs approved by the FDA available for
the treatment of sepsis.
Endothelium, which is widely distributed in the body, is regarded as an
important regulator for the development of sepsis. Besides the essential role in
maintaining the vascular permeability in the cardiovascular system, activated
endothelial cells are also involved in recruiting and facilitating immune cell
migration and transmigration. They do this by expressing adhesion molecules on
the endothelial cells, into myocardium to clear invading pathogens. Uncontrolled
inflammatory responses in myocardium can induce irreversible damage and
subsequent cardiac dysfunction with severe mortality. The NF-κB signal pathway
has been regarded as a critical regulator of inflammatory responses in immune
cells. However, the NF-κB signal pathway plays a key role in the regulation of
adhesion molecule expression in the endothelial cells.
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HSPA12B, as a protein predominately expressed in the endothelial cells,
has been reported to be involved in the regulation of angiogenesis of endothelial
cells. Mounting studies have revealed the protective role of HSPA12B in different
pathophysiological situations. In our current study, we found that HSPA12B
deficiency resulted in severe cardiac dysfunction with increased mortality in CLP
sepsis. Our study also shows that HSPA12B deficiency contributes to higher
levels of adhesion molecules (ICAM1 and VAM1) in the myocardium in CLP
sepsis. To understand how HSPA12B regulates adhesion molecule expression in
endothelial cells during CLP sepsis, we performed in-vitro experiments by
overexpressing HSPA12B in endothelial cells stimulated with LPS stimulation,
which show the downregulation of adhesion molecule expression by HSPA12B.
This downregulation results from suppression of NF-κB subset p65 nuclear
translocation.
Recent evidence highlighted the role of macrophage function in sepsis
induced organ dysfunction. In the present study, we found that HSPA12B
deficiency resulted in increased pro-inflammatory cytokine (TNF-α, and IL-1β)
production and decreased anti-inflammatory cytokine (IL-10) production. The
data suggests the important role of endothelial HSPA12B in regulating immune
responses in CLP sepsis. Other groups have reported that endothelial cells could
modulate macrophage polarization into an M2 state through cell-cell
communication by endothelial exosomes. Interestingly, our previous study has
observed the presence of HSPA12B in serum exosomes from WT mice, and
current studies found that there is no HSPA12B expression in exosomes from the
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organs of HSPA12B deficient mice. In-vitro experiments also confirm the
presence of HSPA12B in endothelial exosomes, which could be uptaken by
macrophages. Moreover, endothelial exosomal HSPA12B can downregulate
inflammatory responses by decreased pro-inflammatory cytokine (TNF-α, and IL1β) production, and increased anti-inflammatory cytokine (IL-10) production.
These decreased inflammatory responses are due to the suppression of NF-κB
subset p65 nuclear translocation in LPS-stimulated macrophages, by endothelial
exosomal HSPA12B. Expressing HSPA12B in macrophages by adenovirus
further confirmed the direct regulation of HSPA12B in LPS-stimulated
macrophage inflammatory responses by preventing NF-κB subset p65 nuclear
translocation.
To investigate how endothelial HSPA12B regulates the infiltration of
monocytes/macrophages into the tissues, we analyzed monocytes/macrophages
in the circulation and spleen by flow cytometry. Interestingly, there are no
changes in the numbers of circulation and splenic monocytes/macrophages in
HSPA12B-/- sham mice, when compared with WT sham control. However, the
numbers of circulating monocytes marked with F4/80+/CD11b+ in HSPA12B-/septic mice were markedly lower than in WT septic mice, while splenic
Ly6C+/CCR2+ macrophages from F4/80+/CD11b+ macrophage populations in
HSPA12B-/- septic mice were greater than in WT septic mice. The data indicates
that endothelial HSPA12B could play an important role in the regulation of
monocyte/macrophage infiltration into the tissues. Although we do not fully
understand how endothelial HSPA12B regulates the infiltration of
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monocytes/macrophages into the tissues during CLP sepsis at present, we
observed that the levels of adhesion molecules in the myocardium were
markedly increased in HSPA12B-/- septic mice compared with WT septic mice.
Increased adhesion molecule expression in HSPA12B could be responsible for
increased infiltration of monocytes/macrophages into the tissues. In our previous
study, we demonstrated that HSPA12B regulates endothelial cell miR-126
expression which targets adhesion molecule expression.
To investigate how to reduce HSPA12B deficiency induced mortality, we
focus on the β-glucan induced trained immunity. Trained immunity contributes to
the formation of immune memory in the innate immune cells, such as
monocyte/macrophages, which protect the host against re-infection with quick
and non-specific immune responses. Moreover, β-glucan is also involved in the
regulation of endothelial cell function. In our present study, we found that βglucan enhanced the levels of HSPA12B in endothelial cells, and even in the
endothelial exosomes. Plus, exosomes from β-glucan treated endothelial cells
can significantly decrease LPS-stimulated macrophage inflammatory responses
by suppression of NF-κB subset p65 nuclear translocation. Furthermore, βglucan trained HSPA12B deficient mice display markedly enhanced survival
outcomes with decreased pro-inflammatory cytokine production in the serum.
To the best of our knowledge, this is the first report that endothelial
HSPA12B can be involved in the communication between endothelial cells and
macrophages by endothelial exosomes, and that endothelial HSPA12B can be
enhanced by β-glucan stimulation. The endothelial exosomal HSPA12B
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regulates macrophage pro-inflammatory cytokine production via attenuation of
NF-B activation.
In the future work, we will investigate the mechanisms by β-glucan
regulates of HSPA12B expression in endothelial cells. Considering the role of βglucan in epigenetic modifications in the trained macrophages, we will examine
whether β-glucan could induce trained endothelial HSPA12B via epigenetic
modification. Moreover, we will test whether β-glucan could induce trained
endothelial cells that will regulate macrophage/monocyte function in CLP sepsis.
Finally, we will define detailed mechanisms by which endothelial HSPA12B
modulates inflammatory cytokine gene expressions in macrophages.
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